
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Longitudinal patterns of antidepressant and benzodiazepine use associated with injurious falls in older adults with depression: a retrospective cohort study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152548DB8AF360230548DB000AD93C3B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcmedicine">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Medicine">
<meta name="citation_title" content="Longitudinal patterns of antidepressant and benzodiazepine use associated with injurious falls in older adults with depression: a retrospective cohort study">
<meta name="citation_author" content="Grace Hsin-Min Wang">
<meta name="citation_author_institution" content="Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA">
<meta name="citation_author" content="Amie J Goodin">
<meta name="citation_author_institution" content="Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA">
<meta name="citation_author" content="Rachel C Reise">
<meta name="citation_author_institution" content="Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA">
<meta name="citation_author" content="Ronald I Shorr">
<meta name="citation_author_institution" content="College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL USA">
<meta name="citation_author_institution" content="North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL USA">
<meta name="citation_author" content="Taewoo Park">
<meta name="citation_author_institution" content="Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA USA">
<meta name="citation_author" content="Wei-Hsuan Lo-Ciganic">
<meta name="citation_author_institution" content="North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL USA">
<meta name="citation_author_institution" content="Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Center for Research On Health Care, 3609 Forbes Avenue, 2nd Floor, Pittsburgh, PA 15213 USA">
<meta name="citation_author_institution" content="Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA USA">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="23">
<meta name="citation_firstpage" content="487">
<meta name="citation_doi" content="10.1186/s12916-025-04325-2">
<meta name="citation_pmid" content="40830788">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/pdf/12916_2025_Article_4325.pdf">
<meta name="description" content="Cross-sectional studies have shown that antidepressants (ADs) and benzodiazepines (BZDs) are commonly co-prescribed for depression, potentially increasing the risk of falls and related injuries (FRI) compared to monotherapies. However, little is ...">
<meta name="og:title" content="Longitudinal patterns of antidepressant and benzodiazepine use associated with injurious falls in older adults with depression: a retrospective cohort study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Cross-sectional studies have shown that antidepressants (ADs) and benzodiazepines (BZDs) are commonly co-prescribed for depression, potentially increasing the risk of falls and related injuries (FRI) compared to monotherapies. However, little is ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366386">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12916-025-04325-2"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12916_2025_Article_4325.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366386%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366386/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366386/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcmedicine.png" alt="BMC Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Medicine" title="Link to BMC Medicine" shape="default" href="https://bmcmedicine.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Med</button></div>. 2025 Aug 20;23:487. doi: <a href="https://doi.org/10.1186/s12916-025-04325-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12916-025-04325-2</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Longitudinal patterns of antidepressant and benzodiazepine use associated with injurious falls in older adults with depression: a retrospective cohort study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20GHM%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Grace Hsin-Min Wang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Grace Hsin-Min Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20GHM%22%5BAuthor%5D" class="usa-link"><span class="name western">Grace Hsin-Min Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goodin%20AJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Amie J Goodin</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Amie J Goodin</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goodin%20AJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Amie J Goodin</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reise%20RC%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Rachel C Reise</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Rachel C Reise</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reise%20RC%22%5BAuthor%5D" class="usa-link"><span class="name western">Rachel C Reise</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shorr%20RI%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ronald I Shorr</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ronald I Shorr</span></h3>
<div class="p">
<sup>2</sup>College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL USA </div>
<div class="p">
<sup>3</sup>North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shorr%20RI%22%5BAuthor%5D" class="usa-link"><span class="name western">Ronald I Shorr</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Taewoo Park</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Taewoo Park</span></h3>
<div class="p">
<sup>4</sup>Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Taewoo Park</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lo-Ciganic%20WH%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Wei-Hsuan Lo-Ciganic</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Wei-Hsuan Lo-Ciganic</span></h3>
<div class="p">
<sup>3</sup>North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL USA </div>
<div class="p">
<sup>5</sup>Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Center for Research On Health Care, 3609 Forbes Avenue, 2nd Floor, Pittsburgh, PA 15213 USA </div>
<div class="p">
<sup>6</sup>Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lo-Ciganic%20WH%22%5BAuthor%5D" class="usa-link"><span class="name western">Wei-Hsuan Lo-Ciganic</span></a>
</div>
</div>
<sup>3,</sup><sup>5,</sup><sup>6,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL USA </div>
<div id="Aff2">
<sup>2</sup>College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL USA </div>
<div id="Aff3">
<sup>3</sup>North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL USA </div>
<div id="Aff4">
<sup>4</sup>Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA USA </div>
<div id="Aff5">
<sup>5</sup>Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Center for Research On Health Care, 3609 Forbes Avenue, 2nd Floor, Pittsburgh, PA 15213 USA </div>
<div id="Aff6">
<sup>6</sup>Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA USA </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 2; Accepted 2025 Aug 6; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366386  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830788/" class="usa-link">40830788</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Cross-sectional studies have shown that antidepressants (ADs) and benzodiazepines (BZDs) are commonly co-prescribed for depression, potentially increasing the risk of falls and related injuries (FRI) compared to monotherapies. However, little is known about the longitudinal dosing patterns (i.e., trajectory) of ADs and BZDs and their associated FRI risk.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">This retrospective cohort study used group-based multi-trajectory models to identify AD-BZD trajectories among older Medicare fee-for-service beneficiaries with depression initiating ADs with/without BZDs. We measured the standardized daily doses of AD and BZD within 84 days after AD initiation and categorized them into negligible, very-low, low, moderate, high, or very-high levels with a discontinuing, declining, increasing, or stable trend. Then, we assessed the subsequent 12-month FRI risk associated with each trajectory.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Among 102,750 eligible beneficiaries, the mean age was 75.5 years (SD = 7.5); 67.0% were female, 81.2% were White, and 4.9% experienced an FRI. We identified 12 distinct AD/BZD trajectories, of which 79,424 patients received AD monotherapy, and 23,326 patients received both ADs and BZDs. Compared with Group A (low discontinuing AD; 17.3% of the cohort; FRI crude incidence rate = 99.7/1000 person-year), trajectories with a higher dose or a longer duration of AD use were associated with an increased FRI risk, regardless of BZD use. The hazard ratios (HR) and 95% confidence intervals (CI) for Groups B (low declining AD; 31.0% of the cohort), C (moderate increasing AD; 23.5%), and D (high increasing AD; 5.4%) were 1.11 (1.04–1.19), 1.24 (1.16–1.32), and 1.29 (1.16–1.42), respectively. Combining ADs and BZDs at very-low doses or with declining trends did not significantly alter FRI risk compared to AD monotherapy. However, FRI risk increased when BZDs were used at low doses (either with stable or increasing trends). The HR and 95%CI for Groups J (moderate increasing AD/low stable BZD, 1.3%) and L (very-high increasing AD/low-dose increasing BZD) were 1.71 (1.41, 2.08) and 1.96 (1.53, 2.49), respectively.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">We observed a dose–response relationship between AD use and FRI risk, independent of BZD use, highlighting the importance of initiating ADs at the lowest effective dose and closely monitoring to prevent FRI.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12916-025-04325-2.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Elderly, Depression, Falls, Fractures, Antidepressants, Benzodiazepines, Trajectory</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par19">Depression affects approximately one-third older adults globally [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>], with 75% experiencing a co-occurring anxiety disorder [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Antidepressants (AD) are the first-line pharmacotherapy for depression, with some guidelines recommending short-term benzodiazepine (BZD) use for managing anxiety or insomnia symptoms, especially during the first 1–4 weeks after AD initiation [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Concurrent AD and BZD use in older adults is common in clinical practice. For example, a study using US commercial insurance claims data found that the co-initiation rate of ADs and BZDs was 12.5% [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. By contrast, long-term concomitant use of BZD is generally not recommended due to the risk of dependency and increased likelihood of adverse outcomes, including falls and related injuries (FRI) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par20">Both ADs and BZDs possess sedative side effects that can impair or exacerbate psychomotor and cognitive functions in older adults, potentially increasing the FRI risk [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. A meta-analysis indicated that the use of ADs or BZDs alone was associated with an increased FRI risk compared to no use (AD: odds ratio [OR] = 1.57, 95% confidence interval [CI] = 1.43–1.74; BZD: OR = 1.42, 95% CI = 1.04–1.56) [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. The 2019 American Geriatric Society Beers Criteria also recommended against combining ADs and BZDs in older adults with a history of falls or fractures, suggesting that concomitant use may further elevate FRI risk [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p>
<p id="Par21">Dose titration and tapering of ADs and BZDs are common in clinical practice; however, existing studies on the concurrent use of ADs and BZDs have not explored how their doses change over time. Additionally, both the dose and duration of drug use may affect the FRI risk [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Understanding the longitudinal utilization patterns (i.e., trajectories) of ADs with or without concurrent BZD use (hereafter “AD ± BZD”) and examining their associations with FRI risk can provide valuable insights to inform safer prescribing and guide future safety monitoring programs. Therefore, we aimed to (1) identify distinct AD ± BZD longitudinal dosing patterns and covariates associated with specific trajectories, and (2) examine the association between these trajectories and the FRI risk among older adults with depression.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<p id="Par22">This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline for reporting observational research (Additional files: Table S1) [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p>
<section id="Sec3"><h3 class="pmc_sec_title">Data Sources</h3>
<p id="Par23">We used Medicare Parts A, B, and D fee-for-service claims data comprised of a 5% sample of beneficiaries (2013–2015) and a 15% modified sample with oversampling of Floridians (2016–2019). The 15% modified sample including the original 5% sample plus additional beneficiaries, which is an oversample of those residing in Florida. All beneficiaries who met the inclusion criteria were followed longitudinally from their entry into the sample until censoring. Thus, individuals from the original 5% sample continued to be followed during the 15% sample period, and the additional beneficiaries included in 2016–2019 were followed starting in 2016. Medicare covers ~ 97% of the US population aged ≥ 65 years [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">Study design and cohort selection</h3>
<p id="Par24">This retrospective cohort study included Medicare beneficiaries initiating ADs with/without BZDs between 2014 and 2019, given that Medicare part D started covering BZDs in 2013 [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. The index date (i.e., day 0) was the date of the first AD fill, and beneficiaries were required to have at least one depression diagnosis within 365 days prior to the index date. We documented daily AD and BZD utilization patterns within 84 days after the index date (i.e., trajectory measurement window). The 84-day window was selected based on typical duration of first-line treatment for depression during the acute phase, as defined by the Healthcare Effectiveness Data and Information Set (HEDIS) measurement (84–114 days) [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>] and consistent with clinical recommendations (6–12 weeks) from UpToDate [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<p id="Par25">We excluded beneficiaries who: (1) were aged &lt; 65 years, (2) did not reside in US, (3) received hospice care or resided in a skilled nursing facility within days [−365, 84] because the caring patterns in these settings were different from community dwelling, (4) switched to Medicare Advantage plan within days [−365, 84], (5) died within days [0, 84], or (6) experienced an FRI event within days [−365, 84]. We excluded beneficiaries who died or experienced an FRI within the 84-day trajectory measurement window to ensure adequate time for exposure classification. Including these individuals could lead to misclassification, as they would not have sufficient time to establish a treatment pattern. We followed patients from day 85 to the earliest of FRI occurrence, death, transition to Medicare Advantage plans, use of hospice services or skilled nursing facilities, or end of the 1-year follow-up (Additional files: Figures S1 and S2).</p></section><section id="Sec5"><h3 class="pmc_sec_title">Exposure</h3>
<p id="Par26">The exposure of interest was the beneficiary’s membership in a distinct trajectory, identified using the group-based multi-trajectory modeling (GBMTM). GBMTM is a data-driven approach to identify distinct longitudinal utilization patterns across multiple medication classes concurrently and to classify individuals into trajectory groups based on the maximum likelihood estimation [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. We applied GBMTM with censored normal distributions, appropriate for repeatedly measured, continuous scales that may be censored at some point [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. The independent variable was the number of days after the index date, and the dependent variables were the standardized daily doses (SDD) of ADs and BZDs.</p>
<p id="Par27">To compute SDD, we determined whether each day was covered by any AD or BZD based on dispensing dates and days supplied [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. The SDD of ADs was calculated by dividing the prescribed daily dose by the defined daily dose (DDD) (Additional files: Table S2) [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. For BZDs, daily dose of BZDs were converted into the diazepam milligram equivalents (DME) using an equivalency conversion table (Additional files: Table S2) [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>–<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. For each patient, the SDDs of individual ADs and BZDs were then summed to obtain total SDDs for ADs and BZDs, respectively. For example, if a patient took fluoxetine 20 mg twice a day (2 DDD), imipramine 75 mg daily (0.75 DDD), alprazolam 0.5 mg three times daily (15 DME), and lorazepam 5 mg daily (30 DME), the resulting SDDs would be 2.75 DDD for ADs and 45 DME for BZDs. When a dispensing occurred before the end of the previous drug supply (i.e., dispensing date plus days supplied), the refill was assumed to begin on the day after the prior supply ended. Lastly, we addressed outliers by replacing values below the 1 st percentile with the 1 st percentile value and those above the 99th percentile with the 99th percentile value [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>].</p>
<p id="Par28">In each GBMTM, we used the most flexible functional form (up to the 4th order polynomial function) of the time variable to allow trajectories to emerge from the data [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Outputs of GBMTM included estimated probabilities of group membership for each individual, estimated trajectory curves over time, and the proportion in each trajectory group. The trajectory models were run separately for patients receiving ADs only (n = 79,424) and those receiving both ADs and BZDs (n = 23,326). For AD initiators with concurrent BZD use, we evaluated models with varying numbers of trajectories (2 to 5) for AD and BZD use, respectively, and then combined parameters from the single-trajectory models to construct the multi-trajectory model. For those without BZD use, we modelled AD use only.</p>
<p id="Par29">The final number of trajectories was selected based on a combination of (1) Bayesian information criteria, wherein the largest value indicates the best-fitting model; (2) Nagin’s criteria for assessing model adequacy (Additional files: Table S3); (3) a minimum of 1% of the cohort assigned to each trajectory (at least 233 patients for AD + BZD trajectories and 794 patients for AD only trajectories); (4) clinical relevance of trajectory patterns [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. We prioritized a parsimonious number of clinically meaningful trajectories that could inform practice and policy. Nagin’s criteria for a well-fitting trajectory model include an average posterior probability of group membership ≥ 0.7, odds of correct classification of ≥ 5.0, and narrow CIs for the estimated group membership probabilities among all groups [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p>
<p id="Par30">To facilitate the labeling of AD and BZD dose levels, we defined AD use as: negligible (SDD &lt; 0.1 DDD), very-low (0.1 to &lt; 0.5 DDD), low (0.5 to &lt; 1 DDD), moderate (1 to &lt; 1.5 DDD), high (1.5 to &lt; 2 DDD) and very high dose (≥ 2 DDD) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Similarly, we defined BZD use as negligible (SDD &lt; 1 DME), very-low (&lt; 5 DME), low (5 to &lt; 10 DME), moderate (10 to &lt; 15 DME), high (15 to &lt; 20 DME) and very-high dose (≥ 20 DME) [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. We defined a “discontinuing” pattern as a dose reduction to the negligible level, “declining” or “increasing” patterns when the absolute change exceeded 0.1 DDD for ADs or 1 DME for BZDs, and “stable” when changes remained below these thresholds.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Outcome</h3>
<p id="Par31">Our outcome of interest was time to first FRI, including falls, bone fractures, sprains, strains, dislocations, and superficial skin injuries in head, neck or trunk, upper limb, and lower limb. In the main analysis, FRI was identified using the acute care algorithm developed and validated by Min et al. (Additional files: Table S4). This method specifically captures the most valid and severe FRIs documented in hospital or emergency department settings, aiming to maximize specificity and minimize misclassification bias (sensitivity = 62.1%, positive predictive value = 88.6%) [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Covariates</h3>
<p id="Par32">Covariates were measured in the year prior to the index date, including socio-demographics, health services utilization, comorbidities (Additional files: Table S5), and concomitant medication use [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Comorbidities were selected based on previous literature and clinical input from two clinicians (R.S. and T.P.), and were considered present if an individual had ≥ 1 diagnosis code in any position in any medical claims. The Elixhauser comorbidity score was also calculated to provide a comprehensive comorbidity assessment [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Use of specific medication classes was defined by ≥ 1 prescription within that class. We calculated the anticholinergic burden score to reflect the cumulative extent of anticholinergic effects [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>], and defined polypharmacy as concurrent use of ≥ 5 different medications [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p></section><section id="Sec8"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par33">Missing data were imputed using the mode for categorical variables and the median for continuous variables. We compared baseline characteristics across the identified trajectories using chi-square tests for categorical variables and analysis of variance for continuous variables. For factors that showed significant differences across trajectories, we further assessed their associations with trajectory group membership using a multinomial logistic regression model. Adjusted ORs with 95% CI were reported.</p>
<p id="Par34">Given that the identified trajectory groups likely differ in patient characteristics and disease complexity, we applied stabilized inverse probability of treatment weighting (IPTW) to balance the groups [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Since our exposure was a multi-level variable (i.e., trajectory groups), propensity scores (PS) for each subject were estimated using a generalized boosted machine algorithm [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. To meet the positivity assumption, we trimmed subjects with extreme PS (top and bottom 5th percentiles) [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>] and removed confounders responsible for positivity violations from the weight construction [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. We also assessed overlap in PS distributions using kernel density curves. Stabilized IPTW was calculated by multiplying each subject’s weight (1/PS) by the prevalence of the assigned trajectory group [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. This approach yields a pseudo-population in which trajectory group membership is independent of measured covariates, thereby minimizing confounding in the assessment of FRI risk [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>–<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. Covariate balance was evaluated using absolute standardized mean differences (ASMDs) [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Imbalanced covariates (ASMD &gt; 0.1 after weighting) were included in the final outcome models to further adjust for residual confounding [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>].</p>
<p id="Par35">We summarized baseline characteristics using mean and standard deviation (SD) for continuous variables and number and percentage for categorical variables. Crude incidence rate of FRI was calculated as the total number of events per 1,000 person-years. Since death is a competing event precluding the outcome from occurring (i.e., individuals who die can no longer experience an FRI event) [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>], we used the Fine-Gray subdistribution hazard model instead of the conventional Cox proportional hazards model to estimate crude and adjusted hazard ratios (HR) with 95%CI for time to first FRI across trajectory groups. We tested the proportional hazards assumption by visual assessment of the plotted Schoenfeld residuals [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. GBMTM was performed using the TRAJ macro in SAS (<a href="http://www.andrew.cmu.edu/user/bjones" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.andrew.cmu.edu/user/bjones</a>). ASMDs and Fine-Gray model were performed using R version 4.2.3. All other analyses were conducted using SAS version 9.4 (SAS Inc., Cary, NC, USA).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Subgroup and sensitivity analyses</h3>
<p id="Par36">We performed a series of subgroup and sensitivity analyses to examine the heterogeneity of effects and ensure the robustness of our findings. For subgroup analyses, we repeated the primary analysis after stratifying the cohort by their frailty and dementia status. Frailty was determined using the claims-based frailty index developed and validated by Kim et al. [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>–<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Beneficiaries were classified as frail if their frailty index exceeded the 25th percentile of the cohort distribution. Dementia was identified using a list of validated International Classification of Diseases, Ninth Revision codes (sensitivity = 0.86, positive predictive value = 0.78) [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>] and Tenth Revision codes (sensitivity = 0.68, positive predictive value = 0.77) [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>].</p>
<p id="Par37">For sensitivity analyses, we first applied an alternative algorithm maximizing the inclusion of FRI events regardless of healthcare settings (sensitivity = 0.68, positive predictive value = 0.75) [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Second, we extended the trajectory measurement window to 182 days (~ 6 months) and began follow-up from day 183 to examine the long-term impact of trajectory membership on the FRI risk. Finally, acknowledging the potential for residual confounding inherent in observational studies, we calculated E-values to evaluate the possible influence of unmeasured confounders [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. E-values represent the minimum strength of association that an unmeasured confounder would need to have with both the exposure and the outcome to fully explain away the association between trajectory membership and the FRI risk [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>].</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec11"><h3 class="pmc_sec_title">Baseline characteristics</h3>
<p id="Par38">Among the 102,750 beneficiaries (mean age = 75.5 years [SD = 7.5]; 67.0% female; 81.2% White), 8.9% experienced an FRI. The most prevalent comorbidity was hyperlipidemia (72.0%), and the most frequently used concomitant medication class was lipid-modifying agents (47.4%). Most covariates were balanced across identified trajectory groups after the IPTW approach (Table <a href="#Tab1" class="usa-link">1</a> and Additional files: Table S6). The average days of supply was 41.0 days (SD = 24.9) for ADs and 29.0 days (SD = 17.5) for BZDs. The mean SDD was 0.8 DDD (SD = 0.6) for ADs and 2.0 DME (SD = 1.8) for BZDs (Table <a href="#Tab2" class="usa-link">2</a>).
</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Patient characteristics of eligible Medicare beneficiaries: Overall and by trajectory</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Trajectory groups<sup>a</sup>
</th>
<th align="left" colspan="1" rowspan="1">All</th>
<th align="left" colspan="1" rowspan="1">A</th>
<th align="left" colspan="1" rowspan="1">B</th>
<th align="left" colspan="1" rowspan="1">C</th>
<th align="left" colspan="1" rowspan="1">D</th>
<th align="left" colspan="1" rowspan="1">E</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">G</th>
<th align="left" colspan="1" rowspan="1">H</th>
<th align="left" colspan="1" rowspan="1">I</th>
<th align="left" colspan="1" rowspan="1">J</th>
<th align="left" colspan="1" rowspan="1">K</th>
<th align="left" colspan="1" rowspan="1">L</th>
<th align="left" colspan="1" rowspan="1">ASMD<sup>‡</sup><br>after IPTW</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Total</td>
<td align="left" colspan="1" rowspan="1">102,750 (100.0)</td>
<td align="left" colspan="1" rowspan="1">17,820 (17.3)</td>
<td align="left" colspan="1" rowspan="1">31,824 (31.0)</td>
<td align="left" colspan="1" rowspan="1">24,194 (23.5)</td>
<td align="left" colspan="1" rowspan="1">5586 (5.4)</td>
<td align="left" colspan="1" rowspan="1">4161 (4.0)</td>
<td align="left" colspan="1" rowspan="1">717 (0.7)</td>
<td align="left" colspan="1" rowspan="1">7004 (6.8)</td>
<td align="left" colspan="1" rowspan="1">1291 (1.3)</td>
<td align="left" colspan="1" rowspan="1">6351 (6.2)</td>
<td align="left" colspan="1" rowspan="1">1308 (1.3)</td>
<td align="left" colspan="1" rowspan="1">1771 (1.7)</td>
<td align="left" colspan="1" rowspan="1">723 (0.7)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">75.5 (7.5)</td>
<td align="left" colspan="1" rowspan="1">75.8 (7.5)</td>
<td align="left" colspan="1" rowspan="1">76.8 (8.0)</td>
<td align="left" colspan="1" rowspan="1">74.7 (7.1)</td>
<td align="left" colspan="1" rowspan="1">73.4 (6.5)</td>
<td align="left" colspan="1" rowspan="1">75.3 (7.2)</td>
<td align="left" colspan="1" rowspan="1">73.4 (6.5)</td>
<td align="left" colspan="1" rowspan="1">76.2 (7.8)</td>
<td align="left" colspan="1" rowspan="1">74.0 (6.9)</td>
<td align="left" colspan="1" rowspan="1">74.6 (7.0)</td>
<td align="left" colspan="1" rowspan="1">73.2 (6.5)</td>
<td align="left" colspan="1" rowspan="1">73.3 (6.4)</td>
<td align="left" colspan="1" rowspan="1">72.2 (6.0)</td>
<td align="left" colspan="1" rowspan="1">0.07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Male, %</td>
<td align="left" colspan="1" rowspan="1">33.0</td>
<td align="left" colspan="1" rowspan="1">31.6</td>
<td align="left" colspan="1" rowspan="1">32.4</td>
<td align="left" colspan="1" rowspan="1">37.0</td>
<td align="left" colspan="1" rowspan="1">36.6</td>
<td align="left" colspan="1" rowspan="1">26.7</td>
<td align="left" colspan="1" rowspan="1">31.7</td>
<td align="left" colspan="1" rowspan="1">28.7</td>
<td align="left" colspan="1" rowspan="1">33.3</td>
<td align="left" colspan="1" rowspan="1">31.8</td>
<td align="left" colspan="1" rowspan="1">33.2</td>
<td align="left" colspan="1" rowspan="1">28.9</td>
<td align="left" colspan="1" rowspan="1">28.6</td>
<td align="left" colspan="1" rowspan="1">0.11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">White, %</td>
<td align="left" colspan="1" rowspan="1">81.2</td>
<td align="left" colspan="1" rowspan="1">78.0</td>
<td align="left" colspan="1" rowspan="1">79.2</td>
<td align="left" colspan="1" rowspan="1">85.0</td>
<td align="left" colspan="1" rowspan="1">86.6</td>
<td align="left" colspan="1" rowspan="1">82.2</td>
<td align="left" colspan="1" rowspan="1">80.8</td>
<td align="left" colspan="1" rowspan="1">79.2</td>
<td align="left" colspan="1" rowspan="1">74.5</td>
<td align="left" colspan="1" rowspan="1">84.3</td>
<td align="left" colspan="1" rowspan="1">75.2</td>
<td align="left" colspan="1" rowspan="1">86.7</td>
<td align="left" colspan="1" rowspan="1">79.1</td>
<td align="left" colspan="1" rowspan="1">0.08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dual eligibility, %</td>
<td align="left" colspan="1" rowspan="1">26.4</td>
<td align="left" colspan="1" rowspan="1">26.4</td>
<td align="left" colspan="1" rowspan="1">29.5</td>
<td align="left" colspan="1" rowspan="1">22.1</td>
<td align="left" colspan="1" rowspan="1">21.7</td>
<td align="left" colspan="1" rowspan="1">22.1</td>
<td align="left" colspan="1" rowspan="1">32.1</td>
<td align="left" colspan="1" rowspan="1">29.2</td>
<td align="left" colspan="1" rowspan="1">40.7</td>
<td align="left" colspan="1" rowspan="1">24.2</td>
<td align="left" colspan="1" rowspan="1">38.1</td>
<td align="left" colspan="1" rowspan="1">24.8</td>
<td align="left" colspan="1" rowspan="1">37.3</td>
<td align="left" colspan="1" rowspan="1">0.11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Frailty, %</td>
<td align="left" colspan="1" rowspan="1">10.6</td>
<td align="left" colspan="1" rowspan="1">9.3</td>
<td align="left" colspan="1" rowspan="1">13.0</td>
<td align="left" colspan="1" rowspan="1">9.1</td>
<td align="left" colspan="1" rowspan="1">7.2</td>
<td align="left" colspan="1" rowspan="1">9.4</td>
<td align="left" colspan="1" rowspan="1">10.0</td>
<td align="left" colspan="1" rowspan="1">13.7</td>
<td align="left" colspan="1" rowspan="1">13.3</td>
<td align="left" colspan="1" rowspan="1">10.0</td>
<td align="left" colspan="1" rowspan="1">9.9</td>
<td align="left" colspan="1" rowspan="1">5.9</td>
<td align="left" colspan="1" rowspan="1">5.5</td>
<td align="left" colspan="1" rowspan="1">0.09</td>
</tr>
<tr><td align="left" colspan="15" rowspan="1">Comorbidities, %</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anxiety disorder</td>
<td align="left" colspan="1" rowspan="1">32.5</td>
<td align="left" colspan="1" rowspan="1">27.0</td>
<td align="left" colspan="1" rowspan="1">25.6</td>
<td align="left" colspan="1" rowspan="1">25.0</td>
<td align="left" colspan="1" rowspan="1">25.6</td>
<td align="left" colspan="1" rowspan="1">57.8</td>
<td align="left" colspan="1" rowspan="1">70.9</td>
<td align="left" colspan="1" rowspan="1">55.5</td>
<td align="left" colspan="1" rowspan="1">64.3</td>
<td align="left" colspan="1" rowspan="1">53.6</td>
<td align="left" colspan="1" rowspan="1">57.6</td>
<td align="left" colspan="1" rowspan="1">47.4</td>
<td align="left" colspan="1" rowspan="1">50.9</td>
<td align="left" colspan="1" rowspan="1">0.13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bipolar disorder</td>
<td align="left" colspan="1" rowspan="1">2.7</td>
<td align="left" colspan="1" rowspan="1">2.0</td>
<td align="left" colspan="1" rowspan="1">2.4</td>
<td align="left" colspan="1" rowspan="1">2.1</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">3.1</td>
<td align="left" colspan="1" rowspan="1">6.7</td>
<td align="left" colspan="1" rowspan="1">3.8</td>
<td align="left" colspan="1" rowspan="1">8.1</td>
<td align="left" colspan="1" rowspan="1">2.9</td>
<td align="left" colspan="1" rowspan="1">7.0</td>
<td align="left" colspan="1" rowspan="1">5.4</td>
<td align="left" colspan="1" rowspan="1">9.4</td>
<td align="left" colspan="1" rowspan="1">0.08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Dementia</td>
<td align="left" colspan="1" rowspan="1">13.6</td>
<td align="left" colspan="1" rowspan="1">10.0</td>
<td align="left" colspan="1" rowspan="1">18.2</td>
<td align="left" colspan="1" rowspan="1">13.2</td>
<td align="left" colspan="1" rowspan="1">10.7</td>
<td align="left" colspan="1" rowspan="1">6.9</td>
<td align="left" colspan="1" rowspan="1">4.5</td>
<td align="left" colspan="1" rowspan="1">14.9</td>
<td align="left" colspan="1" rowspan="1">12.8</td>
<td align="left" colspan="1" rowspan="1">12.0</td>
<td align="left" colspan="1" rowspan="1">12.1</td>
<td align="left" colspan="1" rowspan="1">8.8</td>
<td align="left" colspan="1" rowspan="1">6.8</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hyperlipidemia</td>
<td align="left" colspan="1" rowspan="1">72.0</td>
<td align="left" colspan="1" rowspan="1">73.1</td>
<td align="left" colspan="1" rowspan="1">72.9</td>
<td align="left" colspan="1" rowspan="1">73.6</td>
<td align="left" colspan="1" rowspan="1">65.0</td>
<td align="left" colspan="1" rowspan="1">73.6</td>
<td align="left" colspan="1" rowspan="1">72.8</td>
<td align="left" colspan="1" rowspan="1">73.3</td>
<td align="left" colspan="1" rowspan="1">69.2</td>
<td align="left" colspan="1" rowspan="1">70.4</td>
<td align="left" colspan="1" rowspan="1">62.0</td>
<td align="left" colspan="1" rowspan="1">59.1</td>
<td align="left" colspan="1" rowspan="1">50.9</td>
<td align="left" colspan="1" rowspan="1">0.07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Osteoarthritis</td>
<td align="left" colspan="1" rowspan="1">34.3</td>
<td align="left" colspan="1" rowspan="1">36.8</td>
<td align="left" colspan="1" rowspan="1">36.1</td>
<td align="left" colspan="1" rowspan="1">32.2</td>
<td align="left" colspan="1" rowspan="1">26.8</td>
<td align="left" colspan="1" rowspan="1">38.2</td>
<td align="left" colspan="1" rowspan="1">43.2</td>
<td align="left" colspan="1" rowspan="1">36.0</td>
<td align="left" colspan="1" rowspan="1">36.2</td>
<td align="left" colspan="1" rowspan="1">32.2</td>
<td align="left" colspan="1" rowspan="1">32.1</td>
<td align="left" colspan="1" rowspan="1">23.3</td>
<td align="left" colspan="1" rowspan="1">22.5</td>
<td align="left" colspan="1" rowspan="1">0.10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Osteoporosis</td>
<td align="left" colspan="1" rowspan="1">13.7</td>
<td align="left" colspan="1" rowspan="1">14.9</td>
<td align="left" colspan="1" rowspan="1">14.8</td>
<td align="left" colspan="1" rowspan="1">11.9</td>
<td align="left" colspan="1" rowspan="1">9.5</td>
<td align="left" colspan="1" rowspan="1">17.3</td>
<td align="left" colspan="1" rowspan="1">15.6</td>
<td align="left" colspan="1" rowspan="1">15.8</td>
<td align="left" colspan="1" rowspan="1">14.6</td>
<td align="left" colspan="1" rowspan="1">13.0</td>
<td align="left" colspan="1" rowspan="1">10.7</td>
<td align="left" colspan="1" rowspan="1">8.0</td>
<td align="left" colspan="1" rowspan="1">9.5</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Vision disorder</td>
<td align="left" colspan="1" rowspan="1">52.0</td>
<td align="left" colspan="1" rowspan="1">56.2</td>
<td align="left" colspan="1" rowspan="1">55.3</td>
<td align="left" colspan="1" rowspan="1">50.5</td>
<td align="left" colspan="1" rowspan="1">38.0</td>
<td align="left" colspan="1" rowspan="1">56.0</td>
<td align="left" colspan="1" rowspan="1">49.1</td>
<td align="left" colspan="1" rowspan="1">54.5</td>
<td align="left" colspan="1" rowspan="1">46.0</td>
<td align="left" colspan="1" rowspan="1">48.5</td>
<td align="left" colspan="1" rowspan="1">39.2</td>
<td align="left" colspan="1" rowspan="1">31.6</td>
<td align="left" colspan="1" rowspan="1">25.0</td>
<td align="left" colspan="1" rowspan="1">0.15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Elixhauser Comorbidity Index, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">5.0 (3.0)</td>
<td align="left" colspan="1" rowspan="1">5.1 (3.0)</td>
<td align="left" colspan="1" rowspan="1">5.2 (3.0)</td>
<td align="left" colspan="1" rowspan="1">4.8 (2.9)</td>
<td align="left" colspan="1" rowspan="1">4.2 (2.8)</td>
<td align="left" colspan="1" rowspan="1">5.2 (3.0)</td>
<td align="left" colspan="1" rowspan="1">5.3 (3.0)</td>
<td align="left" colspan="1" rowspan="1">5.3 (3.1)</td>
<td align="left" colspan="1" rowspan="1">5.3 (3.1)</td>
<td align="left" colspan="1" rowspan="1">4.8 (3.0)</td>
<td align="left" colspan="1" rowspan="1">4.6 (3.1)</td>
<td align="left" colspan="1" rowspan="1">3.8 (2.8)</td>
<td align="left" colspan="1" rowspan="1">3.6 (2.7)</td>
<td align="left" colspan="1" rowspan="1">0.07</td>
</tr>
<tr><td align="left" colspan="15" rowspan="1">Comedications, %</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anticonvulsants</td>
<td align="left" colspan="1" rowspan="1">13.8</td>
<td align="left" colspan="1" rowspan="1">11.8</td>
<td align="left" colspan="1" rowspan="1">14.2</td>
<td align="left" colspan="1" rowspan="1">12.9</td>
<td align="left" colspan="1" rowspan="1">13.2</td>
<td align="left" colspan="1" rowspan="1">13.4</td>
<td align="left" colspan="1" rowspan="1">17.2</td>
<td align="left" colspan="1" rowspan="1">16.2</td>
<td align="left" colspan="1" rowspan="1">21.4</td>
<td align="left" colspan="1" rowspan="1">14.0</td>
<td align="left" colspan="1" rowspan="1">20.6</td>
<td align="left" colspan="1" rowspan="1">15.6</td>
<td align="left" colspan="1" rowspan="1">17.8</td>
<td align="left" colspan="1" rowspan="1">0.08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antidementia agents</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">4.8</td>
<td align="left" colspan="1" rowspan="1">10.2</td>
<td align="left" colspan="1" rowspan="1">8.5</td>
<td align="left" colspan="1" rowspan="1">7.1</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">3.1</td>
<td align="left" colspan="1" rowspan="1">8.6</td>
<td align="left" colspan="1" rowspan="1">7.8</td>
<td align="left" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">8.4</td>
<td align="left" colspan="1" rowspan="1">6.9</td>
<td align="left" colspan="1" rowspan="1">9.3</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antiparkinsonian agents</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
<td align="left" colspan="1" rowspan="1">2.7</td>
<td align="left" colspan="1" rowspan="1">3.9</td>
<td align="left" colspan="1" rowspan="1">3.5</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">2.9</td>
<td align="left" colspan="1" rowspan="1">2.9</td>
<td align="left" colspan="1" rowspan="1">4.4</td>
<td align="left" colspan="1" rowspan="1">6.1</td>
<td align="left" colspan="1" rowspan="1">3.9</td>
<td align="left" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">4.2</td>
<td align="left" colspan="1" rowspan="1">5.0</td>
<td align="left" colspan="1" rowspan="1">0.07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antipsychotics</td>
<td align="left" colspan="1" rowspan="1">5.2</td>
<td align="left" colspan="1" rowspan="1">3.1</td>
<td align="left" colspan="1" rowspan="1">4.8</td>
<td align="left" colspan="1" rowspan="1">4.1</td>
<td align="left" colspan="1" rowspan="1">6.7</td>
<td align="left" colspan="1" rowspan="1">4.2</td>
<td align="left" colspan="1" rowspan="1">7.1</td>
<td align="left" colspan="1" rowspan="1">7.1</td>
<td align="left" colspan="1" rowspan="1">16.7</td>
<td align="left" colspan="1" rowspan="1">7.2</td>
<td align="left" colspan="1" rowspan="1">15.1</td>
<td align="left" colspan="1" rowspan="1">9.9</td>
<td align="left" colspan="1" rowspan="1">16.9</td>
<td align="left" colspan="1" rowspan="1">0.09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anxiolytics†</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">0.9</td>
<td align="left" colspan="1" rowspan="1">0.9</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">0.9</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">1.4</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">1.4</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Beta blockers</td>
<td align="left" colspan="1" rowspan="1">33.3</td>
<td align="left" colspan="1" rowspan="1">32.7</td>
<td align="left" colspan="1" rowspan="1">34.8</td>
<td align="left" colspan="1" rowspan="1">32.7</td>
<td align="left" colspan="1" rowspan="1">27.9</td>
<td align="left" colspan="1" rowspan="1">35.8</td>
<td align="left" colspan="1" rowspan="1">38.9</td>
<td align="left" colspan="1" rowspan="1">36.0</td>
<td align="left" colspan="1" rowspan="1">33.8</td>
<td align="left" colspan="1" rowspan="1">32.5</td>
<td align="left" colspan="1" rowspan="1">30.2</td>
<td align="left" colspan="1" rowspan="1">24.3</td>
<td align="left" colspan="1" rowspan="1">26.3</td>
<td align="left" colspan="1" rowspan="1">0.11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hypnotics/sedatives†</td>
<td align="left" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">4.2</td>
<td align="left" colspan="1" rowspan="1">4.2</td>
<td align="left" colspan="1" rowspan="1">4.1</td>
<td align="left" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">6.1</td>
<td align="left" colspan="1" rowspan="1">7.8</td>
<td align="left" colspan="1" rowspan="1">6.0</td>
<td align="left" colspan="1" rowspan="1">7.4</td>
<td align="left" colspan="1" rowspan="1">6.3</td>
<td align="left" colspan="1" rowspan="1">8.6</td>
<td align="left" colspan="1" rowspan="1">7.5</td>
<td align="left" colspan="1" rowspan="1">8.3</td>
<td align="left" colspan="1" rowspan="1">0.04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Opioids</td>
<td align="left" colspan="1" rowspan="1">13.6</td>
<td align="left" colspan="1" rowspan="1">13.1</td>
<td align="left" colspan="1" rowspan="1">12.3</td>
<td align="left" colspan="1" rowspan="1">11.5</td>
<td align="left" colspan="1" rowspan="1">11.5</td>
<td align="left" colspan="1" rowspan="1">17.2</td>
<td align="left" colspan="1" rowspan="1">33.8</td>
<td align="left" colspan="1" rowspan="1">16.2</td>
<td align="left" colspan="1" rowspan="1">31.4</td>
<td align="left" colspan="1" rowspan="1">14.6</td>
<td align="left" colspan="1" rowspan="1">27.3</td>
<td align="left" colspan="1" rowspan="1">16.7</td>
<td align="left" colspan="1" rowspan="1">27.1</td>
<td align="left" colspan="1" rowspan="1">0.09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Psychostimulants</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">2.2</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">0.8</td>
<td align="left" colspan="1" rowspan="1">1.9</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">3.7</td>
<td align="left" colspan="1" rowspan="1">0.02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anticholinergic burden index, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">1.5 (1.9)</td>
<td align="left" colspan="1" rowspan="1">1.2 (1.7)</td>
<td align="left" colspan="1" rowspan="1">1.3 (1.8)</td>
<td align="left" colspan="1" rowspan="1">1.2 (1.7)</td>
<td align="left" colspan="1" rowspan="1">1.2 (1.6)</td>
<td align="left" colspan="1" rowspan="1">2.0 (1.8)</td>
<td align="left" colspan="1" rowspan="1">2.8 (2.2)</td>
<td align="left" colspan="1" rowspan="1">2.2 (2.1)</td>
<td align="left" colspan="1" rowspan="1">2.9 (2.4)</td>
<td align="left" colspan="1" rowspan="1">2.0 (1.9)</td>
<td align="left" colspan="1" rowspan="1">2.8 (2.3)</td>
<td align="left" colspan="1" rowspan="1">1.8 (1.8)</td>
<td align="left" colspan="1" rowspan="1">2.2 (1.9)</td>
<td align="left" colspan="1" rowspan="1">0.17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Polypharmacy, %</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
<td align="left" colspan="1" rowspan="1">8.9</td>
<td align="left" colspan="1" rowspan="1">11.8</td>
<td align="left" colspan="1" rowspan="1">10.4</td>
<td align="left" colspan="1" rowspan="1">8.9</td>
<td align="left" colspan="1" rowspan="1">9.8</td>
<td align="left" colspan="1" rowspan="1">13.8</td>
<td align="left" colspan="1" rowspan="1">12.7</td>
<td align="left" colspan="1" rowspan="1">15.5</td>
<td align="left" colspan="1" rowspan="1">11.2</td>
<td align="left" colspan="1" rowspan="1">14.8</td>
<td align="left" colspan="1" rowspan="1">9.5</td>
<td align="left" colspan="1" rowspan="1">11.2</td>
<td align="left" colspan="1" rowspan="1">0.10</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p27">
<p>To facilitate the labeling of AD and BZD dose levels for each trajectory, we defined AD use as: negligible (standardized daily dose [SDD] &lt; 0.1 defined daily dose [DDD]), very low (0.1 to &lt; 0.5 DDD), low (0.5 to &lt; 1 DDD), moderate (1 to &lt; 1.5 DDD), high (1.5 to &lt; 2 DDD) and very high dose (≥ 2 DDD). Similarly, we defined BZD use as negligible (SDD &lt; 1 diazepam milligram equivalent [DME]), very-low (&lt; 5 DME), low (5 to &lt; 10 DME), moderate (10 to &lt; 15 DME), high (15 to &lt; 20 DME) and very-high dose (≥ 20 DME). We defined a “discontinuing” pattern as a dose reduction to the negligible level, “declining” or “increasing” patterns when the absolute change exceeded 0.1 DDD for ADs or 1 DME for BZDs, and “stable” when changes remained below these thresholds</p>
<p><em>Abbreviations: </em><em>AD</em> Antidepressants, <em>ASMD</em> Absolute standardized mean difference, <em>BZD</em> Benzodiazepine, <em>SD</em> Standard deviation</p>
<p><sup>a﻿</sup>Trajectory groups: A: low discontinuing AD (17.3% of the cohort); B: low declining AD (31.0%); C: moderate increasing AD (23.5%); D: high increasing AD (5.4%); E: low discontinuing AD/very-low declining BZD (4.0%); F: low discontinuing AD/low declining BZD (0.7%); G: low declining AD/very-low declining BZD (6.8%); H: low declining AD/low declining BZD (1.3%); I: moderate increasing AD/very-low declining BZD (6.2%); J: moderate increasing AD/low stable BZD (1.3%); K: very-high increasing AD/very-low stable BZD (1.7%); L: very-high increasing AD/low-dose increasing BZD (0.7%)</p>
<p><sup>†</sup>Benzodiazepines were not included in the medication classes of anxiolytics and hypnotics/sedatives</p>
<p><sup>‡</sup>Median ASMD of 66 ASMDs from group comparisons (the number of 2-combinations from 12 trajectories: <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq1"><math id="d33e1495"><mrow><msubsup><mi>c</mi><mn>2</mn><mn>12</mn></msubsup><mspace width="0.277778em"></mspace><mo>=</mo><mspace width="0.277778em"></mspace><mn>66</mn></mrow></math></span>; (e.g., group A vs B, A vs C)</p>
</div></div></section><section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Patterns of antidepressant and benzodiazepine use during 12-month trajectory measurement period by trajectory group</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Trajectory groups<sup>a</sup>
</th>
<th align="left" colspan="1" rowspan="1">All</th>
<th align="left" colspan="1" rowspan="1">A</th>
<th align="left" colspan="1" rowspan="1">B</th>
<th align="left" colspan="1" rowspan="1">C</th>
<th align="left" colspan="1" rowspan="1">D</th>
<th align="left" colspan="1" rowspan="1">E</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">G</th>
<th align="left" colspan="1" rowspan="1">H</th>
<th align="left" colspan="1" rowspan="1">I</th>
<th align="left" colspan="1" rowspan="1">J</th>
<th align="left" colspan="1" rowspan="1">K</th>
<th align="left" colspan="1" rowspan="1">L</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="14" rowspan="1"><strong>Antidepressants‡</strong></td></tr>
<tr><td align="left" colspan="14" rowspan="1">
<strong>Subclass</strong><strong>, </strong><strong>%</strong>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> SSRI</td>
<td align="left" colspan="1" rowspan="1">59.4</td>
<td align="left" colspan="1" rowspan="1">50.1</td>
<td align="left" colspan="1" rowspan="1">49.8</td>
<td align="left" colspan="1" rowspan="1">75.3</td>
<td align="left" colspan="1" rowspan="1">61.4</td>
<td align="left" colspan="1" rowspan="1">54.8</td>
<td align="left" colspan="1" rowspan="1">45.9</td>
<td align="left" colspan="1" rowspan="1">47.6</td>
<td align="left" colspan="1" rowspan="1">37.2</td>
<td align="left" colspan="1" rowspan="1">70.9</td>
<td align="left" colspan="1" rowspan="1">59.6</td>
<td align="left" colspan="1" rowspan="1">58.1</td>
<td align="left" colspan="1" rowspan="1">47.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> SNRI</td>
<td align="left" colspan="1" rowspan="1">11.8</td>
<td align="left" colspan="1" rowspan="1">11.7</td>
<td align="left" colspan="1" rowspan="1">11.8</td>
<td align="left" colspan="1" rowspan="1">9.7</td>
<td align="left" colspan="1" rowspan="1">14.3</td>
<td align="left" colspan="1" rowspan="1">12.6</td>
<td align="left" colspan="1" rowspan="1">17.1</td>
<td align="left" colspan="1" rowspan="1">12.4</td>
<td align="left" colspan="1" rowspan="1">14.3</td>
<td align="left" colspan="1" rowspan="1">10.3</td>
<td align="left" colspan="1" rowspan="1">15.1</td>
<td align="left" colspan="1" rowspan="1">16.4</td>
<td align="left" colspan="1" rowspan="1">25.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> TCA</td>
<td align="left" colspan="1" rowspan="1">3.2</td>
<td align="left" colspan="1" rowspan="1">5.1</td>
<td align="left" colspan="1" rowspan="1">4.4</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">2.6</td>
<td align="left" colspan="1" rowspan="1">5.7</td>
<td align="left" colspan="1" rowspan="1">6.2</td>
<td align="left" colspan="1" rowspan="1">4.5</td>
<td align="left" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">1.3</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">2.7</td>
<td align="left" colspan="1" rowspan="1">3.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Individual drugs, %</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Sertraline</td>
<td align="left" colspan="1" rowspan="1">19.8</td>
<td align="left" colspan="1" rowspan="1">16.5</td>
<td align="left" colspan="1" rowspan="1">17.0</td>
<td align="left" colspan="1" rowspan="1">24.6</td>
<td align="left" colspan="1" rowspan="1">24.5</td>
<td align="left" colspan="1" rowspan="1">16.7</td>
<td align="left" colspan="1" rowspan="1">13.0</td>
<td align="left" colspan="1" rowspan="1">14.8</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
<td align="left" colspan="1" rowspan="1">21.7</td>
<td align="left" colspan="1" rowspan="1">16.5</td>
<td align="left" colspan="1" rowspan="1">21.0</td>
<td align="left" colspan="1" rowspan="1">17.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Escitalopram</td>
<td align="left" colspan="1" rowspan="1">18.9</td>
<td align="left" colspan="1" rowspan="1">16.1</td>
<td align="left" colspan="1" rowspan="1">12.2</td>
<td align="left" colspan="1" rowspan="1">27.3</td>
<td align="left" colspan="1" rowspan="1">18.9</td>
<td align="left" colspan="1" rowspan="1">19.3</td>
<td align="left" colspan="1" rowspan="1">15.7</td>
<td align="left" colspan="1" rowspan="1">12.8</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
<td align="left" colspan="1" rowspan="1">27.3</td>
<td align="left" colspan="1" rowspan="1">21.2</td>
<td align="left" colspan="1" rowspan="1">19.3</td>
<td align="left" colspan="1" rowspan="1">12.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Citalopram</td>
<td align="left" colspan="1" rowspan="1">10.7</td>
<td align="left" colspan="1" rowspan="1">9.5</td>
<td align="left" colspan="1" rowspan="1">11.9</td>
<td align="left" colspan="1" rowspan="1">11.9</td>
<td align="left" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">9.8</td>
<td align="left" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
<td align="left" colspan="1" rowspan="1">7.4</td>
<td align="left" colspan="1" rowspan="1">10.7</td>
<td align="left" colspan="1" rowspan="1">8.4</td>
<td align="left" colspan="1" rowspan="1">5.8</td>
<td align="left" colspan="1" rowspan="1">5.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mirtazapine</td>
<td align="left" colspan="1" rowspan="1">9.2</td>
<td align="left" colspan="1" rowspan="1">8.6</td>
<td align="left" colspan="1" rowspan="1">14.1</td>
<td align="left" colspan="1" rowspan="1">4.6</td>
<td align="left" colspan="1" rowspan="1">4.1</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">6.9</td>
<td align="left" colspan="1" rowspan="1">14.1</td>
<td align="left" colspan="1" rowspan="1">12.8</td>
<td align="left" colspan="1" rowspan="1">6.9</td>
<td align="left" colspan="1" rowspan="1">8.3</td>
<td align="left" colspan="1" rowspan="1">6.1</td>
<td align="left" colspan="1" rowspan="1">6.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Trazodone</td>
<td align="left" colspan="1" rowspan="1">8.3</td>
<td align="left" colspan="1" rowspan="1">10.3</td>
<td align="left" colspan="1" rowspan="1">12.4</td>
<td align="left" colspan="1" rowspan="1">2.8</td>
<td align="left" colspan="1" rowspan="1">4.8</td>
<td align="left" colspan="1" rowspan="1">11.0</td>
<td align="left" colspan="1" rowspan="1">9.6</td>
<td align="left" colspan="1" rowspan="1">14.6</td>
<td align="left" colspan="1" rowspan="1">18.5</td>
<td align="left" colspan="1" rowspan="1">5.1</td>
<td align="left" colspan="1" rowspan="1">5.4</td>
<td align="left" colspan="1" rowspan="1">6.6</td>
<td align="left" colspan="1" rowspan="1">7.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bupropion</td>
<td align="left" colspan="1" rowspan="1">7.2</td>
<td align="left" colspan="1" rowspan="1">6.6</td>
<td align="left" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">6.2</td>
<td align="left" colspan="1" rowspan="1">12.8</td>
<td align="left" colspan="1" rowspan="1">5.6</td>
<td align="left" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">8.4</td>
<td align="left" colspan="1" rowspan="1">5.3</td>
<td align="left" colspan="1" rowspan="1">8.0</td>
<td align="left" colspan="1" rowspan="1">9.8</td>
<td align="left" colspan="1" rowspan="1">8.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Duloxetine</td>
<td align="left" colspan="1" rowspan="1">7.2</td>
<td align="left" colspan="1" rowspan="1">8.3</td>
<td align="left" colspan="1" rowspan="1">8.5</td>
<td align="left" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">3.0</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">9.6</td>
<td align="left" colspan="1" rowspan="1">8.5</td>
<td align="left" colspan="1" rowspan="1">10.3</td>
<td align="left" colspan="1" rowspan="1">6.3</td>
<td align="left" colspan="1" rowspan="1">9.4</td>
<td align="left" colspan="1" rowspan="1">3.4</td>
<td align="left" colspan="1" rowspan="1">5.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fluoxetine</td>
<td align="left" colspan="1" rowspan="1">6.2</td>
<td align="left" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">5.0</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">8.0</td>
<td align="left" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">5.4</td>
<td align="left" colspan="1" rowspan="1">4.3</td>
<td align="left" colspan="1" rowspan="1">3.8</td>
<td align="left" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">7.6</td>
<td align="left" colspan="1" rowspan="1">7.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Paroxetine</td>
<td align="left" colspan="1" rowspan="1">3.4</td>
<td align="left" colspan="1" rowspan="1">3.1</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">2.4</td>
<td align="left" colspan="1" rowspan="1">3.7</td>
<td align="left" colspan="1" rowspan="1">3.4</td>
<td align="left" colspan="1" rowspan="1">4.3</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
<td align="left" colspan="1" rowspan="1">3.9</td>
<td align="left" colspan="1" rowspan="1">4.9</td>
<td align="left" colspan="1" rowspan="1">3.7</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Venlafaxine</td>
<td align="left" colspan="1" rowspan="1">3.4</td>
<td align="left" colspan="1" rowspan="1">2.8</td>
<td align="left" colspan="1" rowspan="1">3.1</td>
<td align="left" colspan="1" rowspan="1">3.0</td>
<td align="left" colspan="1" rowspan="1">4.2</td>
<td align="left" colspan="1" rowspan="1">3.1</td>
<td align="left" colspan="1" rowspan="1">4.6</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
<td align="left" colspan="1" rowspan="1">4.6</td>
<td align="left" colspan="1" rowspan="1">5.2</td>
<td align="left" colspan="1" rowspan="1">7.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Amitriptyline</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">2.2</td>
<td align="left" colspan="1" rowspan="1">2.4</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">2.3</td>
<td align="left" colspan="1" rowspan="1">2.5</td>
<td align="left" colspan="1" rowspan="1">2.3</td>
<td align="left" colspan="1" rowspan="1">2.9</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Desvenlafaxine</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">6.9</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">2.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.9</td>
<td align="left" colspan="1" rowspan="1">7.5</td>
<td align="left" colspan="1" rowspan="1">12.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Doxepin</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">2.3</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">1.8</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.9</td>
<td align="left" colspan="1" rowspan="1">0.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Nortriptyline</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">1.2</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">1.3</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Tryptophan</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">5.8</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Vortioxetine</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Imipramine</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Vilazodone</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">1.3</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">2.2</td>
<td align="left" colspan="1" rowspan="1">5.4</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Perphenazine</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fluvoxamine</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
</tr>
<tr><td align="left" colspan="14" rowspan="1"><strong>Utilization, mean (SD)</strong></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Days of supply</td>
<td align="left" colspan="1" rowspan="1">41.0 (24.9)</td>
<td align="left" colspan="1" rowspan="1">27.7 (7.4)</td>
<td align="left" colspan="1" rowspan="1">40.1 (23.9)</td>
<td align="left" colspan="1" rowspan="1">44.5 (27.2)</td>
<td align="left" colspan="1" rowspan="1">49.4 (29.2)</td>
<td align="left" colspan="1" rowspan="1">29.1 (5.6)</td>
<td align="left" colspan="1" rowspan="1">29.1 (7.6)</td>
<td align="left" colspan="1" rowspan="1">39.0 (22.8)</td>
<td align="left" colspan="1" rowspan="1">37.7 (22.0)</td>
<td align="left" colspan="1" rowspan="1">42.3 (25.9)</td>
<td align="left" colspan="1" rowspan="1">40.8 (24.4)</td>
<td align="left" colspan="1" rowspan="1">46.2 (28.2)</td>
<td align="left" colspan="1" rowspan="1">43.1 (26.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> SDD</td>
<td align="left" colspan="1" rowspan="1">0.8 (0.6)</td>
<td align="left" colspan="1" rowspan="1">0.7 (0.5)</td>
<td align="left" colspan="1" rowspan="1">0.5 (0.3)</td>
<td align="left" colspan="1" rowspan="1">0.9 (0.3)</td>
<td align="left" colspan="1" rowspan="1">1.5 (0.9)</td>
<td align="left" colspan="1" rowspan="1">0.7 (0.5)</td>
<td align="left" colspan="1" rowspan="1">0.8 (0.5)</td>
<td align="left" colspan="1" rowspan="1">0.5 (0.3)</td>
<td align="left" colspan="1" rowspan="1">0.5 (0.3)</td>
<td align="left" colspan="1" rowspan="1">0.9 (0.4)</td>
<td align="left" colspan="1" rowspan="1">1.0 (0.4)</td>
<td align="left" colspan="1" rowspan="1">1.5 (0.9)</td>
<td align="left" colspan="1" rowspan="1">1.6 (1.0)</td>
</tr>
<tr><td align="left" colspan="14" rowspan="1"><strong>Benzodiazepines‡</strong></td></tr>
<tr><td align="left" colspan="14" rowspan="1">
<strong>Subclass</strong><strong>, </strong><strong>%</strong>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Intermediate-acting</td>
<td align="left" colspan="1" rowspan="1">48.0</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">44.7</td>
<td align="left" colspan="1" rowspan="1">49.0</td>
<td align="left" colspan="1" rowspan="1">46.7</td>
<td align="left" colspan="1" rowspan="1">59.7</td>
<td align="left" colspan="1" rowspan="1">45.2</td>
<td align="left" colspan="1" rowspan="1">55.9</td>
<td align="left" colspan="1" rowspan="1">41.5</td>
<td align="left" colspan="1" rowspan="1">47.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Short-acting</td>
<td align="left" colspan="1" rowspan="1">30.8</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">33.6</td>
<td align="left" colspan="1" rowspan="1">32.1</td>
<td align="left" colspan="1" rowspan="1">32.1</td>
<td align="left" colspan="1" rowspan="1">24.8</td>
<td align="left" colspan="1" rowspan="1">32.7</td>
<td align="left" colspan="1" rowspan="1">24.3</td>
<td align="left" colspan="1" rowspan="1">32.2</td>
<td align="left" colspan="1" rowspan="1">27.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Long-acting</td>
<td align="left" colspan="1" rowspan="1">21.2</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">21.7</td>
<td align="left" colspan="1" rowspan="1">18.9</td>
<td align="left" colspan="1" rowspan="1">21.3</td>
<td align="left" colspan="1" rowspan="1">15.5</td>
<td align="left" colspan="1" rowspan="1">22.1</td>
<td align="left" colspan="1" rowspan="1">19.8</td>
<td align="left" colspan="1" rowspan="1">26.2</td>
<td align="left" colspan="1" rowspan="1">24.5</td>
</tr>
<tr><td align="left" colspan="14" rowspan="1">
<strong>Individual drugs</strong><strong>, </strong><strong>%</strong>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Lorazepam</td>
<td align="left" colspan="1" rowspan="1">40.9</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">39.6</td>
<td align="left" colspan="1" rowspan="1">41.1</td>
<td align="left" colspan="1" rowspan="1">40.4</td>
<td align="left" colspan="1" rowspan="1">48.8</td>
<td align="left" colspan="1" rowspan="1">39.6</td>
<td align="left" colspan="1" rowspan="1">44.7</td>
<td align="left" colspan="1" rowspan="1">36.1</td>
<td align="left" colspan="1" rowspan="1">37.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Alprazolam</td>
<td align="left" colspan="1" rowspan="1">30.6</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">33.4</td>
<td align="left" colspan="1" rowspan="1">31.9</td>
<td align="left" colspan="1" rowspan="1">31.8</td>
<td align="left" colspan="1" rowspan="1">24.5</td>
<td align="left" colspan="1" rowspan="1">32.5</td>
<td align="left" colspan="1" rowspan="1">24.2</td>
<td align="left" colspan="1" rowspan="1">31.9</td>
<td align="left" colspan="1" rowspan="1">27.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Clonazepam</td>
<td align="left" colspan="1" rowspan="1">14.3</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">11.3</td>
<td align="left" colspan="1" rowspan="1">14.9</td>
<td align="left" colspan="1" rowspan="1">12.9</td>
<td align="left" colspan="1" rowspan="1">13.6</td>
<td align="left" colspan="1" rowspan="1">13.9</td>
<td align="left" colspan="1" rowspan="1">16.9</td>
<td align="left" colspan="1" rowspan="1">17.7</td>
<td align="left" colspan="1" rowspan="1">22.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Temazepam</td>
<td align="left" colspan="1" rowspan="1">7.1</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">5.1</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">6.2</td>
<td align="left" colspan="1" rowspan="1">10.9</td>
<td align="left" colspan="1" rowspan="1">5.6</td>
<td align="left" colspan="1" rowspan="1">11.1</td>
<td align="left" colspan="1" rowspan="1">5.5</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Diazepam</td>
<td align="left" colspan="1" rowspan="1">4.9</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">8.2</td>
<td align="left" colspan="1" rowspan="1">3.2</td>
<td align="left" colspan="1" rowspan="1">5.9</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">5.7</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">6.0</td>
<td align="left" colspan="1" rowspan="1">1.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Chlordiazepoxide</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">1.5</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">1.8</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">1.9</td>
<td align="left" colspan="1" rowspan="1">1.1</td>
<td align="left" colspan="1" rowspan="1">1.7</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Clorazepate</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.6</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Triazolam</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Oxazepam</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
</tr>
<tr><td align="left" colspan="14" rowspan="1"><strong>Utilization, mean (SD)</strong></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Days of supply</td>
<td align="left" colspan="1" rowspan="1">29.0 (17.5)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">27.8 (16.9)</td>
<td align="left" colspan="1" rowspan="1">32.8 (16.3)</td>
<td align="left" colspan="1" rowspan="1">27.9 (17.5)</td>
<td align="left" colspan="1" rowspan="1">29.5 (16.3)</td>
<td align="left" colspan="1" rowspan="1">28.1 (17.7)</td>
<td align="left" colspan="1" rowspan="1">30.6 (16.6)</td>
<td align="left" colspan="1" rowspan="1">30.5 (19.7)</td>
<td align="left" colspan="1" rowspan="1">31.8 (19.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> SDD</td>
<td align="left" colspan="1" rowspan="1">2.0 (1.8)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">1.4 (1.0)</td>
<td align="left" colspan="1" rowspan="1">3.6 (2.4)</td>
<td align="left" colspan="1" rowspan="1">1.4 (0.9)</td>
<td align="left" colspan="1" rowspan="1">3.4 (2.4)</td>
<td align="left" colspan="1" rowspan="1">1.4 (0.9)</td>
<td align="left" colspan="1" rowspan="1">3.4 (2.5)</td>
<td align="left" colspan="1" rowspan="1">1.6 (1.1)</td>
<td align="left" colspan="1" rowspan="1">3.8 (3.0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p33">
<p>To facilitate the labeling of AD and BZD dose levels for each trajectory, we defined AD use as: negligible (standardized daily dose [SDD] &lt; 0.1 defined daily dose [DDD]), very low (0.1 to &lt; 0.5 DDD), low (0.5 to &lt; 1 DDD), moderate (1 to &lt; 1.5 DDD), high (1.5 to &lt; 2 DDD) and very high dose (≥ 2 DDD). Similarly, we defined BZD use as negligible (SDD &lt; 1 diazepam milligram equivalent [DME]), very-low (&lt; 5 DME), low (5 to &lt; 10 DME), moderate (10 to &lt; 15 DME), high (15 to &lt; 20 DME) and very-high dose (≥ 20 DME). We defined a “discontinuing” pattern as a dose reduction to the negligible level, “declining” or “increasing” patterns when the absolute change exceeded 0.1 DDD for ADs or 1 DME for BZDs, and “stable” when changes remained below these thresholds</p>
<p><em>Abbreviations:</em>
<em>SSRI</em> Selective serotonin reuptake inhibitors, <em>SNRI</em> Serotonin and norepinephrine reuptake inhibitors, <em>TCA</em> Tricyclic antidepressants, <em>SD</em> Standard deviation, <em>SDD</em> Standardized daily dose</p>
<p><sup>a</sup>Trajectory groups: A: low discontinuing AD (17.3% of the cohort); B: low declining AD (31.0%); C: moderate increasing AD (23.5%); D: high increasing AD (5.4%); E: low discontinuing AD/very-low declining BZD (4.0%); F: low discontinuing AD/low declining BZD (0.7%); G: low declining AD/very-low declining BZD (6.8%); H: low declining AD/low declining BZD (1.3%); I: moderate increasing AD/very-low declining BZD (6.2%); J: moderate increasing AD/low stable BZD (1.3%); K: very-high increasing AD/very-low stable BZD (1.7%); L: very-high increasing AD/low-dose increasing BZD (0.7%)</p>
<p><sup>‡</sup>The medications shown in the table were the initial medications patients used (i.e., index drug)</p>
</div></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Covariates associated with membership in AD-BZD trajectories</h3>
<p id="Par39">We identified 12 distinct AD-BZD trajectories (Fig. <a href="#Fig1" class="usa-link">1</a>), organized to improve interpretability based on (1) whether BZDs were co-prescribed (AD-only: Groups A–D; AD + BZD: Groups E–L), (2) increasing AD dose levels (negligible to very-high), and (3) increasing BZD dose levels (negligible to very-high): Group A: low discontinuing AD (17.3% of the cohort); B: low declining AD (31.0%); C: moderate increasing AD (23.5%); D: high increasing AD (5.4%); E: low discontinuing AD/very-low declining BZD (4.0%); F: low discontinuing AD/low declining BZD (0.7%); G: low declining AD/very-low declining BZD (6.8%); H: low declining AD/low declining BZD (1.3%); I: moderate increasing AD/very-low declining BZD (6.2%); J: moderate increasing AD/low stable BZD (1.3%); K: very-high increasing AD/very-low stable BZD (1.7%); L: very-high increasing AD/low increasing BZD (0.7%).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366386_12916_2025_4325_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0363/12366386/7d55f396d1c6/12916_2025_4325_Fig1_HTML.jpg" loading="lazy" id="MO1" height="991" width="699" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Trajectories of antidepressant and benzodiazepine utilization patterns. *Trajectory groups: A: low discontinuing AD (17.3% of the cohort); B: low declining AD (31.0%); C: moderate increasing AD (23.5%); D: high increasing AD (5.4%); E: low discontinuing AD/very-low declining BZD (4.0%); F: low discontinuing AD/low declining BZD (0.7%); G: low declining AD/very-low declining BZD (6.8%); H: low declining AD/low declining BZD (1.3%); I: moderate increasing AD/very-low declining BZD (6.2%); J: moderate increasing AD/low stable BZD (1.3%); K: very-high increasing AD/very-low stable BZD (1.7%); L: very-high increasing AD/low-dose increasing BZD (0.7%). To facilitate the labeling of AD and BZD dose levels for each trajectory, we defined AD use as: negligible (standardized daily dose [SDD] &lt; 0.1 defined daily dose [DDD]), very low (0.1 to &lt; 0.5 DDD), low (0.5 to &lt; 1 DDD), moderate (1 to &lt; 1.5 DDD), high (1.5 to &lt; 2 DDD) and very high dose (≥ 2 DDD). Similarly, we defined BZD use as negligible (SDD &lt; 1 diazepam milligram equivalent [DME]), very-low (&lt; 5 DME), low (5 to &lt; 10 DME), moderate (10 to &lt; 15 DME), high (15 to &lt; 20 DME) and very-high dose (≥ 20 DME). We defined a “discontinuing” pattern as a dose reduction to the negligible level, “declining” or “increasing” patterns when the absolute change exceeded 0.1 DDD for ADs or 1 DME for BZDs, and “stable” when changes remained below these thresholds</p></figcaption></figure><p id="Par40">Table <a href="#Tab3" class="usa-link">3</a> presents the covariates associated with membership in AD-BZD trajectories. Patients were more likely to be in trajectories with higher AD doses (e.g., Groups B, C, and D) if they had a diagnosis of dementia, a higher frailty index, or received medications such as anticonvulsants, antidementia agents, antiparkinsonian agents, or antipsychotics. For example, when comparing Group D vs. A, dementia was associated with an OR of 1.26 (95% CI: 1.11–1.44); frailty index, OR 1.27 (1.10–1.47); anticonvulsants, OR 1.20 (1.08–1.33); antidementia agents, OR 1.49 (1.28–1.73); antiparkinsonian agents, OR 1.30 (1.06–1.60); and antipsychotics, OR 1.69 (1.45–1.98). Conversely, patients were more likely to be in trajectories with higher BZD doses (e.g., Group F vs. A) if they had anxiety (OR = 6.22, 95%CI = 5.25–7.38) or bipolar disorders (OR = 2.28, 95% CI = 1.60–3.26), or if they received antipsychotics (OR = 1.51, 95%CI = 1.08–2.11), beta blockers (OR = 1.36, 95%CI = 1.15–1.62), or psychostimulants (OR = 3.34, 95%CI = 1.88–5.94).
</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Covariates significantly associated with membership in AD ± BZD trajectories</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Trajectory groups<sup>a</sup>
</th>
<th align="left" colspan="1" rowspan="1">B</th>
<th align="left" colspan="1" rowspan="1">C</th>
<th align="left" colspan="1" rowspan="1">D</th>
<th align="left" colspan="1" rowspan="1">E</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">G</th>
<th align="left" colspan="1" rowspan="1">H</th>
<th align="left" colspan="1" rowspan="1">I</th>
<th align="left" colspan="1" rowspan="1">J</th>
<th align="left" colspan="1" rowspan="1">K</th>
<th align="left" colspan="1" rowspan="1">L</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="12" rowspan="1"><strong>Patient-level</strong></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Disability</td>
<td align="left" colspan="1" rowspan="1">0.85 (0.76, 0.95)</td>
<td align="left" colspan="1" rowspan="1">0.68 (0.60, 0.76)</td>
<td align="left" colspan="1" rowspan="1">0.58 (0.47, 0.71)</td>
<td align="left" colspan="1" rowspan="1">0.48 (0.37, 0.61)</td>
<td align="left" colspan="1" rowspan="1">0.37 (0.23, 0.59)</td>
<td align="left" colspan="1" rowspan="1">0.44 (0.36, 0.54)</td>
<td align="left" colspan="1" rowspan="1">0.36 (0.24, 0.52)</td>
<td align="left" colspan="1" rowspan="1">0.46 (0.37, 0.56)</td>
<td align="left" colspan="1" rowspan="1">0.38 (0.26, 0.56)</td>
<td align="left" colspan="1" rowspan="1">0.32 (0.21, 0.50)</td>
<td align="left" colspan="1" rowspan="1">0.19 (0.09, 0.39)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Metropolitan</td>
<td align="left" colspan="1" rowspan="1">1.14 (1.08, 1.20)</td>
<td align="left" colspan="1" rowspan="1">1.09 (1.03, 1.15)</td>
<td align="left" colspan="1" rowspan="1">1.26 (1.15, 1.38)</td>
<td align="left" colspan="1" rowspan="1">1.13 (1.03, 1.25)</td>
<td align="left" colspan="1" rowspan="1">0.99 (0.80, 1.22)</td>
<td align="left" colspan="1" rowspan="1">1.27 (1.17, 1.38)</td>
<td align="left" colspan="1" rowspan="1">1.32 (1.11, 1.57)</td>
<td align="left" colspan="1" rowspan="1">1.29 (1.19, 1.41)</td>
<td align="left" colspan="1" rowspan="1">1.56 (1.29, 1.89)</td>
<td align="left" colspan="1" rowspan="1">1.52 (1.29, 1.80)</td>
<td align="left" colspan="1" rowspan="1">1.29 (0.99, 1.66)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Frailty</td>
<td align="left" colspan="1" rowspan="1">1.08 (1.00, 1.17)</td>
<td align="left" colspan="1" rowspan="1">1.11 (1.02, 1.21)</td>
<td align="left" colspan="1" rowspan="1">1.27 (1.10, 1.47)</td>
<td align="left" colspan="1" rowspan="1">1.00 (0.86, 1.15)</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.75, 1.38)</td>
<td align="left" colspan="1" rowspan="1">1.07 (0.96, 1.20)</td>
<td align="left" colspan="1" rowspan="1">0.96 (0.77, 1.20)</td>
<td align="left" colspan="1" rowspan="1">1.09 (0.96, 1.23)</td>
<td align="left" colspan="1" rowspan="1">1.05 (0.82, 1.34)</td>
<td align="left" colspan="1" rowspan="1">1.07 (0.83, 1.37)</td>
<td align="left" colspan="1" rowspan="1">1.18 (0.80, 1.76)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anxiety disorder</td>
<td align="left" colspan="1" rowspan="1">0.99 (0.94, 1.03)</td>
<td align="left" colspan="1" rowspan="1">0.99 (0.95, 1.04)</td>
<td align="left" colspan="1" rowspan="1">1.06 (0.98, 1.13)</td>
<td align="left" colspan="1" rowspan="1">3.60 (3.35, 3.87)</td>
<td align="left" colspan="1" rowspan="1">6.22 (5.25, 7.38)</td>
<td align="left" colspan="1" rowspan="1">3.42 (3.22, 3.64)</td>
<td align="left" colspan="1" rowspan="1">4.99 (4.40, 5.66)</td>
<td align="left" colspan="1" rowspan="1">3.32 (3.12, 3.53)</td>
<td align="left" colspan="1" rowspan="1">4.24 (3.75, 4.80)</td>
<td align="left" colspan="1" rowspan="1">2.89 (2.61, 3.21)</td>
<td align="left" colspan="1" rowspan="1">3.66 (3.12, 4.30)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bipolar disorder</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.89, 1.18)</td>
<td align="left" colspan="1" rowspan="1">0.89 (0.77, 1.04)</td>
<td align="left" colspan="1" rowspan="1">0.91 (0.74, 1.12)</td>
<td align="left" colspan="1" rowspan="1">1.40 (1.11, 1.75)</td>
<td align="left" colspan="1" rowspan="1">2.28 (1.60, 3.26)</td>
<td align="left" colspan="1" rowspan="1">1.27 (1.06, 1.53)</td>
<td align="left" colspan="1" rowspan="1">1.62 (1.24, 2.11)</td>
<td align="left" colspan="1" rowspan="1">0.91 (0.74, 1.11)</td>
<td align="left" colspan="1" rowspan="1">1.37 (1.04, 1.80)</td>
<td align="left" colspan="1" rowspan="1">1.16 (0.89, 1.51)</td>
<td align="left" colspan="1" rowspan="1">1.54 (1.12, 2.12)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Dementia</td>
<td align="left" colspan="1" rowspan="1">1.57 (1.46, 1.69)</td>
<td align="left" colspan="1" rowspan="1">1.41 (1.30, 1.53)</td>
<td align="left" colspan="1" rowspan="1">1.26 (1.11, 1.44)</td>
<td align="left" colspan="1" rowspan="1">0.76 (0.65, 0.90)</td>
<td align="left" colspan="1" rowspan="1">0.51 (0.34, 0.77)</td>
<td align="left" colspan="1" rowspan="1">1.23 (1.10, 1.37)</td>
<td align="left" colspan="1" rowspan="1">1.11 (0.89, 1.39)</td>
<td align="left" colspan="1" rowspan="1">1.26 (1.12, 1.42)</td>
<td align="left" colspan="1" rowspan="1">1.30 (1.04, 1.64)</td>
<td align="left" colspan="1" rowspan="1">0.99 (0.79, 1.23)</td>
<td align="left" colspan="1" rowspan="1">0.69 (0.48, 0.99)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hyperlipidemia</td>
<td align="left" colspan="1" rowspan="1">0.90 (0.86, 0.95)</td>
<td align="left" colspan="1" rowspan="1">0.93 (0.88, 0.98)</td>
<td align="left" colspan="1" rowspan="1">0.75 (0.69, 0.81)</td>
<td align="left" colspan="1" rowspan="1">0.91 (0.84, 1.00)</td>
<td align="left" colspan="1" rowspan="1">0.98 (0.81, 1.19)</td>
<td align="left" colspan="1" rowspan="1">0.89 (0.83, 0.96)</td>
<td align="left" colspan="1" rowspan="1">0.88 (0.76, 1.01)</td>
<td align="left" colspan="1" rowspan="1">0.79 (0.74, 0.86)</td>
<td align="left" colspan="1" rowspan="1">0.70 (0.61, 0.81)</td>
<td align="left" colspan="1" rowspan="1">0.69 (0.61, 0.78)</td>
<td align="left" colspan="1" rowspan="1">0.65 (0.54, 0.78)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Urinary incontinence</td>
<td align="left" colspan="1" rowspan="1">1.00 (0.94, 1.06)</td>
<td align="left" colspan="1" rowspan="1">0.95 (0.89, 1.02)</td>
<td align="left" colspan="1" rowspan="1">0.98 (0.88, 1.09)</td>
<td align="left" colspan="1" rowspan="1">0.84 (0.75, 0.95)</td>
<td align="left" colspan="1" rowspan="1">0.74 (0.57, 0.96)</td>
<td align="left" colspan="1" rowspan="1">0.87 (0.79, 0.95)</td>
<td align="left" colspan="1" rowspan="1">0.93 (0.77, 1.11)</td>
<td align="left" colspan="1" rowspan="1">0.79 (0.71, 0.87)</td>
<td align="left" colspan="1" rowspan="1">0.64 (0.51, 0.80)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.72, 1.04)</td>
<td align="left" colspan="1" rowspan="1">0.91 (0.68, 1.21)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Vertigo</td>
<td align="left" colspan="1" rowspan="1">0.89 (0.84, 0.94)</td>
<td align="left" colspan="1" rowspan="1">0.81 (0.76, 0.86)</td>
<td align="left" colspan="1" rowspan="1">0.73 (0.66, 0.81)</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.93, 1.12)</td>
<td align="left" colspan="1" rowspan="1">0.87 (0.70, 1.08)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.80, 0.94)</td>
<td align="left" colspan="1" rowspan="1">0.92 (0.78, 1.09)</td>
<td align="left" colspan="1" rowspan="1">0.83 (0.76, 0.91)</td>
<td align="left" colspan="1" rowspan="1">0.71 (0.59, 0.86)</td>
<td align="left" colspan="1" rowspan="1">0.72 (0.60, 0.86)</td>
<td align="left" colspan="1" rowspan="1">0.77 (0.58, 1.03)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antiarrhythmic agents (class 1 &amp; 3)</td>
<td align="left" colspan="1" rowspan="1">0.85 (0.75, 0.97)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.74, 0.99)</td>
<td align="left" colspan="1" rowspan="1">0.65 (0.49, 0.85)</td>
<td align="left" colspan="1" rowspan="1">1.22 (0.98, 1.51)</td>
<td align="left" colspan="1" rowspan="1">1.19 (0.73, 1.94)</td>
<td align="left" colspan="1" rowspan="1">1.03 (0.85, 1.24)</td>
<td align="left" colspan="1" rowspan="1">1.19 (0.80, 1.76)</td>
<td align="left" colspan="1" rowspan="1">0.94 (0.77, 1.16)</td>
<td align="left" colspan="1" rowspan="1">0.94 (0.60, 1.49)</td>
<td align="left" colspan="1" rowspan="1">1.11 (0.76, 1.61)</td>
<td align="left" colspan="1" rowspan="1">1.89 (1.12, 3.20)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anticonvulsants</td>
<td align="left" colspan="1" rowspan="1">1.16 (1.09, 1.24)</td>
<td align="left" colspan="1" rowspan="1">1.14 (1.06, 1.22)</td>
<td align="left" colspan="1" rowspan="1">1.20 (1.08, 1.33)</td>
<td align="left" colspan="1" rowspan="1">1.09 (0.98, 1.23)</td>
<td align="left" colspan="1" rowspan="1">1.01 (0.81, 1.27)</td>
<td align="left" colspan="1" rowspan="1">1.20 (1.10, 1.31)</td>
<td align="left" colspan="1" rowspan="1">1.25 (1.06, 1.48)</td>
<td align="left" colspan="1" rowspan="1">1.15 (1.04, 1.26)</td>
<td align="left" colspan="1" rowspan="1">1.29 (1.09, 1.53)</td>
<td align="left" colspan="1" rowspan="1">1.24 (1.06, 1.45)</td>
<td align="left" colspan="1" rowspan="1">1.16 (0.92, 1.45)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antidementia agents</td>
<td align="left" colspan="1" rowspan="1">1.46 (1.34, 1.60)</td>
<td align="left" colspan="1" rowspan="1">1.63 (1.48, 1.80)</td>
<td align="left" colspan="1" rowspan="1">1.49 (1.28, 1.73)</td>
<td align="left" colspan="1" rowspan="1">0.90 (0.73, 1.11)</td>
<td align="left" colspan="1" rowspan="1">0.97 (0.60, 1.58)</td>
<td align="left" colspan="1" rowspan="1">1.45 (1.27, 1.65)</td>
<td align="left" colspan="1" rowspan="1">1.24 (0.96, 1.61)</td>
<td align="left" colspan="1" rowspan="1">1.41 (1.23, 1.63)</td>
<td align="left" colspan="1" rowspan="1">1.30 (1.00, 1.67)</td>
<td align="left" colspan="1" rowspan="1">1.58 (1.25, 2.01)</td>
<td align="left" colspan="1" rowspan="1">2.08 (1.50, 2.88)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antiparkinsonian agents</td>
<td align="left" colspan="1" rowspan="1">1.32 (1.16, 1.50)</td>
<td align="left" colspan="1" rowspan="1">1.24 (1.08, 1.43)</td>
<td align="left" colspan="1" rowspan="1">1.30 (1.06, 1.60)</td>
<td align="left" colspan="1" rowspan="1">1.11 (0.88, 1.42)</td>
<td align="left" colspan="1" rowspan="1">0.95 (0.57, 1.58)</td>
<td align="left" colspan="1" rowspan="1">1.36 (1.13, 1.63)</td>
<td align="left" colspan="1" rowspan="1">1.65 (1.21, 2.23)</td>
<td align="left" colspan="1" rowspan="1">1.39 (1.15, 1.68)</td>
<td align="left" colspan="1" rowspan="1">1.39 (1.00, 1.92)</td>
<td align="left" colspan="1" rowspan="1">1.40 (1.04, 1.89)</td>
<td align="left" colspan="1" rowspan="1">1.58 (1.04, 2.39)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antipsychotics</td>
<td align="left" colspan="1" rowspan="1">1.17 (1.05, 1.31)</td>
<td align="left" colspan="1" rowspan="1">1.19 (1.05, 1.34)</td>
<td align="left" colspan="1" rowspan="1">1.69 (1.45, 1.98)</td>
<td align="left" colspan="1" rowspan="1">1.23 (1.01, 1.49)</td>
<td align="left" colspan="1" rowspan="1">1.51 (1.08, 2.11)</td>
<td align="left" colspan="1" rowspan="1">1.47 (1.27, 1.70)</td>
<td align="left" colspan="1" rowspan="1">2.75 (2.23, 3.39)</td>
<td align="left" colspan="1" rowspan="1">1.75 (1.51, 2.03)</td>
<td align="left" colspan="1" rowspan="1">2.27 (1.83, 2.80)</td>
<td align="left" colspan="1" rowspan="1">1.95 (1.59, 2.40)</td>
<td align="left" colspan="1" rowspan="1">2.41 (1.87, 3.11)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anxiolytics<sup>†</sup>
</td>
<td align="left" colspan="1" rowspan="1">0.98 (0.79, 1.22)</td>
<td align="left" colspan="1" rowspan="1">0.83 (0.65, 1.05)</td>
<td align="left" colspan="1" rowspan="1">0.91 (0.64, 1.30)</td>
<td align="left" colspan="1" rowspan="1">0.37 (0.26, 0.54)</td>
<td align="left" colspan="1" rowspan="1">0.10 (0.04, 0.28)</td>
<td align="left" colspan="1" rowspan="1">0.34 (0.25, 0.46)</td>
<td align="left" colspan="1" rowspan="1">0.29 (0.18, 0.49)</td>
<td align="left" colspan="1" rowspan="1">0.29 (0.20, 0.41)</td>
<td align="left" colspan="1" rowspan="1">0.24 (0.14, 0.41)</td>
<td align="left" colspan="1" rowspan="1">0.35 (0.21, 0.60)</td>
<td align="left" colspan="1" rowspan="1">0.34 (0.17, 0.69)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Beta blockers</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.97, 1.06)</td>
<td align="left" colspan="1" rowspan="1">1.01 (0.97, 1.06)</td>
<td align="left" colspan="1" rowspan="1">0.97 (0.90, 1.05)</td>
<td align="left" colspan="1" rowspan="1">1.14 (1.05, 1.23)</td>
<td align="left" colspan="1" rowspan="1">1.36 (1.15, 1.62)</td>
<td align="left" colspan="1" rowspan="1">1.08 (1.01, 1.15)</td>
<td align="left" colspan="1" rowspan="1">1.10 (0.96, 1.27)</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.95, 1.10)</td>
<td align="left" colspan="1" rowspan="1">1.03 (0.89, 1.18)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.75, 0.97)</td>
<td align="left" colspan="1" rowspan="1">1.13 (0.93, 1.37)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Diuretics</td>
<td align="left" colspan="1" rowspan="1">1.08 (1.02, 1.13)</td>
<td align="left" colspan="1" rowspan="1">1.11 (1.06, 1.17)</td>
<td align="left" colspan="1" rowspan="1">1.09 (1.00, 1.19)</td>
<td align="left" colspan="1" rowspan="1">0.80 (0.73, 0.88)</td>
<td align="left" colspan="1" rowspan="1">0.71 (0.58, 0.88)</td>
<td align="left" colspan="1" rowspan="1">0.84 (0.78, 0.91)</td>
<td align="left" colspan="1" rowspan="1">0.79 (0.68, 0.93)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.80, 0.93)</td>
<td align="left" colspan="1" rowspan="1">0.94 (0.81, 1.10)</td>
<td align="left" colspan="1" rowspan="1">0.87 (0.75, 1.00)</td>
<td align="left" colspan="1" rowspan="1">0.67 (0.53, 0.85)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Lipid-modifying agents</td>
<td align="left" colspan="1" rowspan="1">1.28 (1.23, 1.34)</td>
<td align="left" colspan="1" rowspan="1">1.41 (1.35, 1.47)</td>
<td align="left" colspan="1" rowspan="1">1.42 (1.32, 1.53)</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.95, 1.11)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.72, 1.02)</td>
<td align="left" colspan="1" rowspan="1">1.25 (1.17, 1.34)</td>
<td align="left" colspan="1" rowspan="1">1.08 (0.95, 1.24)</td>
<td align="left" colspan="1" rowspan="1">1.38 (1.29, 1.48)</td>
<td align="left" colspan="1" rowspan="1">1.27 (1.11, 1.45)</td>
<td align="left" colspan="1" rowspan="1">1.46 (1.30, 1.64)</td>
<td align="left" colspan="1" rowspan="1">1.26 (1.05, 1.51)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Psychostimulants</td>
<td align="left" colspan="1" rowspan="1">1.27 (0.95, 1.68)</td>
<td align="left" colspan="1" rowspan="1">1.29 (0.97, 1.73)</td>
<td align="left" colspan="1" rowspan="1">2.55 (1.84, 3.54)</td>
<td align="left" colspan="1" rowspan="1">1.80 (1.18, 2.74)</td>
<td align="left" colspan="1" rowspan="1">3.34 (1.88, 5.94)</td>
<td align="left" colspan="1" rowspan="1">1.87 (1.30, 2.69)</td>
<td align="left" colspan="1" rowspan="1">2.30 (1.35, 3.91)</td>
<td align="left" colspan="1" rowspan="1">1.49 (1.02, 2.17)</td>
<td align="left" colspan="1" rowspan="1">2.62 (1.62, 4.25)</td>
<td align="left" colspan="1" rowspan="1">1.90 (1.18, 3.04)</td>
<td align="left" colspan="1" rowspan="1">3.89 (2.39, 6.35)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Steroids</td>
<td align="left" colspan="1" rowspan="1">0.88 (0.81, 0.96)</td>
<td align="left" colspan="1" rowspan="1">0.85 (0.77, 0.93)</td>
<td align="left" colspan="1" rowspan="1">0.79 (0.67, 0.92)</td>
<td align="left" colspan="1" rowspan="1">1.01 (0.87, 1.17)</td>
<td align="left" colspan="1" rowspan="1">0.81 (0.58, 1.13)</td>
<td align="left" colspan="1" rowspan="1">0.93 (0.81, 1.05)</td>
<td align="left" colspan="1" rowspan="1">1.01 (0.79, 1.28)</td>
<td align="left" colspan="1" rowspan="1">0.88 (0.77, 1.01)</td>
<td align="left" colspan="1" rowspan="1">0.86 (0.66, 1.12)</td>
<td align="left" colspan="1" rowspan="1">1.01 (0.81, 1.27)</td>
<td align="left" colspan="1" rowspan="1">0.56 (0.36, 0.86)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anticholinergic burden index</td>
<td align="left" colspan="1" rowspan="1">1.02 (1.01, 1.04)</td>
<td align="left" colspan="1" rowspan="1">1.03 (1.01, 1.04)</td>
<td align="left" colspan="1" rowspan="1">1.05 (1.02, 1.07)</td>
<td align="left" colspan="1" rowspan="1">1.32 (1.29, 1.34)</td>
<td align="left" colspan="1" rowspan="1">1.49 (1.44, 1.54)</td>
<td align="left" colspan="1" rowspan="1">1.34 (1.32, 1.36)</td>
<td align="left" colspan="1" rowspan="1">1.47 (1.43, 1.51)</td>
<td align="left" colspan="1" rowspan="1">1.34 (1.32, 1.36)</td>
<td align="left" colspan="1" rowspan="1">1.50 (1.46, 1.55)</td>
<td align="left" colspan="1" rowspan="1">1.35 (1.31, 1.39)</td>
<td align="left" colspan="1" rowspan="1">1.43 (1.37, 1.49)</td>
</tr>
<tr><td align="left" colspan="12" rowspan="1">
<strong>Provider-level</strong><sup>§</sup>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Monthly patients receiving AD</td>
<td align="left" colspan="1" rowspan="1">0.93 (0.87, 0.99)</td>
<td align="left" colspan="1" rowspan="1">0.90 (0.84, 0.96)</td>
<td align="left" colspan="1" rowspan="1">0.97 (0.89, 1.05)</td>
<td align="left" colspan="1" rowspan="1">0.64 (0.57, 0.72)</td>
<td align="left" colspan="1" rowspan="1">0.63 (0.52, 0.77)</td>
<td align="left" colspan="1" rowspan="1">0.68 (0.62, 0.74)</td>
<td align="left" colspan="1" rowspan="1">0.67 (0.59, 0.75)</td>
<td align="left" colspan="1" rowspan="1">0.63 (0.58, 0.69)</td>
<td align="left" colspan="1" rowspan="1">0.68 (0.60, 0.76)</td>
<td align="left" colspan="1" rowspan="1">0.71 (0.63, 0.79)</td>
<td align="left" colspan="1" rowspan="1">0.66 (0.58, 0.76)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Monthly patients receiving BZD</td>
<td align="left" colspan="1" rowspan="1">1.08 (0.98, 1.18)</td>
<td align="left" colspan="1" rowspan="1">1.19 (1.08, 1.31)</td>
<td align="left" colspan="1" rowspan="1">1.19 (1.06, 1.34)</td>
<td align="left" colspan="1" rowspan="1">1.88 (1.66, 2.13)</td>
<td align="left" colspan="1" rowspan="1">2.06 (1.69, 2.52)</td>
<td align="left" colspan="1" rowspan="1">1.85 (1.67, 2.06)</td>
<td align="left" colspan="1" rowspan="1">1.96 (1.71, 2.25)</td>
<td align="left" colspan="1" rowspan="1">2.02 (1.82, 2.25)</td>
<td align="left" colspan="1" rowspan="1">1.81 (1.57, 2.09)</td>
<td align="left" colspan="1" rowspan="1">1.80 (1.56, 2.07)</td>
<td align="left" colspan="1" rowspan="1">1.89 (1.61, 2.22)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Monthly AD dose</td>
<td align="left" colspan="1" rowspan="1">0.97 (0.96, 0.98)</td>
<td align="left" colspan="1" rowspan="1">1.01 (1.00, 1.02)</td>
<td align="left" colspan="1" rowspan="1">1.04 (1.03, 1.06)</td>
<td align="left" colspan="1" rowspan="1">1.02 (1.01, 1.04)</td>
<td align="left" colspan="1" rowspan="1">1.05 (1.03, 1.07)</td>
<td align="left" colspan="1" rowspan="1">1.01 (1.00, 1.02)</td>
<td align="left" colspan="1" rowspan="1">1.04 (1.02, 1.05)</td>
<td align="left" colspan="1" rowspan="1">1.02 (1.01, 1.03)</td>
<td align="left" colspan="1" rowspan="1">1.03 (1.02, 1.04)</td>
<td align="left" colspan="1" rowspan="1">1.04 (1.03, 1.05)</td>
<td align="left" colspan="1" rowspan="1">1.04 (1.03, 1.06)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p41">
<p>To facilitate the labeling of AD and BZD dose levels for each trajectory, we defined AD use as: negligible (standardized daily dose [SDD] &lt; 0.1 defined daily dose [DDD]), very low (0.1 to &lt; 0.5 DDD), low (0.5 to &lt; 1 DDD), moderate (1 to &lt; 1.5 DDD), high (1.5 to &lt; 2 DDD) and very high dose (≥ 2 DDD). Similarly, we defined BZD use as negligible (SDD &lt; 1 diazepam milligram equivalent [DME]), very-low (&lt; 5 DME), low (5 to &lt; 10 DME), moderate (10 to &lt; 15 DME), high (15 to &lt; 20 DME) and very-high dose (≥ 20 DME). We defined a “discontinuing” pattern as a dose reduction to the negligible level, “declining” or “increasing” patterns when the absolute change exceeded 0.1 DDD for ADs or 1 DME for BZDs, and “stable” when changes remained below these thresholds</p>
<p>Each cell represents the adjusted odds ratio for the membership in each trajectory group compared to Group A. For simplicity, we only showed patient characteristics significantly associated with the membership in each trajectory group</p>
<p>Abbreviations: <em>ACEI</em> Angiotensin converting enzyme inhibitor, <em>AD</em> Antidepressants, <em>ARB</em> Angiotensin receptor blocker, <em>BZD</em> Benzodiazepine, <em>ED</em> Emergency department, <em>NSAID</em> Nonsteroidal anti-inflammatory drug, <em>SD</em> Standard deviation</p>
<p><sup>a</sup>Trajectory groups: A: low discontinuing AD (17.3% of the cohort); B: low declining AD (31.0%); C: moderate increasing AD (23.5%); D: high increasing AD (5.4%); E: low discontinuing AD/very-low declining BZD (4.0%); F: low discontinuing AD/low declining BZD (0.7%); G: low declining AD/very-low declining BZD (6.8%); H: low declining AD/low declining BZD (1.3%); I: moderate increasing AD/very-low declining BZD (6.2%); J: moderate increasing AD/low stable BZD (1.3%); K: very-high increasing AD/very-low stable BZD (1.7%); L: very-high increasing AD/low-dose increasing BZD (0.7%)</p>
<p><sup>†</sup>Benzodiazepines were not included in the medication classes of anxiolytics and hypnotics/sedatives</p>
<p><sup>§</sup>The provider was identified as the first physician who recorded the diagnosis of depression in the patient’s medical records. The missingness of the provider-related factors was 22.1%</p>
</div></div></section></section><section id="Sec13"><h3 class="pmc_sec_title">FRI risk associated with each trajectory</h3>
<p id="Par41">Compared to Group A (incidence rate = 99.7/1000 person-year), Groups B (HR = 1.11, 95%CI = 1.04, 1.19), C (HR = 1.24, 95%CI = 1.16, 1.32), and D (HR = 1.29, 95%CI = 1.16, 1.42) were more likely to experience FRI during the 1-year follow-up (Table <a href="#Tab4" class="usa-link">4</a>). In contrast, Group E was associated with a slightly lower risk of FRI (HR = 0.84, 95%CI = 0.73, 0.96), while Group F showed no significant association (HR = 1.09, 95%CI = 0.78, 1.52). Other trajectories with higher AD and/or BZD doses than Group A were also associated with an increased FRI risk, ranging from Group G (HR = 1.15, 95% CI: 1.04–1.27) to Group L (HR = 1.96, 95% CI: 1.53–2.49). The E-values for groups with significant associations ranged from 1.47 to 3.32, suggesting moderate robustness to potential unmeasured confounding.
</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Trajectories of antidepressant and benzodiazepine utilization patterns and 12-month risk of falls and related injuries among medicare beneficiaries (n = 102,750)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Trajectory group<sup>a</sup>
</th>
<th align="left" colspan="1" rowspan="1">Number of patients (% of the cohort)</th>
<th align="left" colspan="1" rowspan="1">Number of FRI events</th>
<th align="left" colspan="1" rowspan="1">Median follow-up days (IQR)</th>
<th align="left" colspan="1" rowspan="1">Median days to FRI (IQR)</th>
<th align="left" colspan="1" rowspan="1">Incidence rate (/1000 person-year)</th>
<th align="left" colspan="1" rowspan="1">Crude HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">Adjusted HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">E-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">17,820 (17.3)</td>
<td align="left" colspan="1" rowspan="1">1373</td>
<td align="left" colspan="1" rowspan="1">365 (170)</td>
<td align="left" colspan="1" rowspan="1">155 (179)</td>
<td align="left" colspan="1" rowspan="1">99.70</td>
<td align="left" colspan="1" rowspan="1">Reference</td>
<td align="left" colspan="1" rowspan="1">Reference</td>
<td align="left" colspan="1" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">B</td>
<td align="left" colspan="1" rowspan="1">31,824 (31.0)</td>
<td align="left" colspan="1" rowspan="1">2864</td>
<td align="left" colspan="1" rowspan="1">365 (194)</td>
<td align="left" colspan="1" rowspan="1">147 (181)</td>
<td align="left" colspan="1" rowspan="1">120.41</td>
<td align="left" colspan="1" rowspan="1">1.21 (1.13, 1.29)</td>
<td align="left" colspan="1" rowspan="1">1.11 (1.04, 1.19)</td>
<td align="left" colspan="1" rowspan="1">1.47</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">24,194 (23.5)</td>
<td align="left" colspan="1" rowspan="1">2197</td>
<td align="left" colspan="1" rowspan="1">365 (164)</td>
<td align="left" colspan="1" rowspan="1">146 (180)</td>
<td align="left" colspan="1" rowspan="1">116.86</td>
<td align="left" colspan="1" rowspan="1">1.17 (1.10, 1.25)</td>
<td align="left" colspan="1" rowspan="1">1.24 (1.16, 1.32)</td>
<td align="left" colspan="1" rowspan="1">1.78</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">D</td>
<td align="left" colspan="1" rowspan="1">5,586 (5.4)</td>
<td align="left" colspan="1" rowspan="1">538</td>
<td align="left" colspan="1" rowspan="1">365 (125)</td>
<td align="left" colspan="1" rowspan="1">159 (185)</td>
<td align="left" colspan="1" rowspan="1">118.84</td>
<td align="left" colspan="1" rowspan="1">1.19 (1.08, 1.32)</td>
<td align="left" colspan="1" rowspan="1">1.29 (1.16, 1.42)</td>
<td align="left" colspan="1" rowspan="1">1.90</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">E</td>
<td align="left" colspan="1" rowspan="1">4,161 (4.0)</td>
<td align="left" colspan="1" rowspan="1">267</td>
<td align="left" colspan="1" rowspan="1">365 (151)</td>
<td align="left" colspan="1" rowspan="1">183 (198)</td>
<td align="left" colspan="1" rowspan="1">81.31</td>
<td align="left" colspan="1" rowspan="1">0.82 (0.72, 0.93)</td>
<td align="left" colspan="1" rowspan="1">0.84 (0.73, 0.96)</td>
<td align="left" colspan="1" rowspan="1">1.21</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">717 (0.7)</td>
<td align="left" colspan="1" rowspan="1">63</td>
<td align="left" colspan="1" rowspan="1">365 (122)</td>
<td align="left" colspan="1" rowspan="1">133 (172)</td>
<td align="left" colspan="1" rowspan="1">109.32</td>
<td align="left" colspan="1" rowspan="1">1.10 (0.85, 1.41)</td>
<td align="left" colspan="1" rowspan="1">1.09 (0.78, 1.52)</td>
<td align="left" colspan="1" rowspan="1">1.40</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">7,004 (6.8)</td>
<td align="left" colspan="1" rowspan="1">615</td>
<td align="left" colspan="1" rowspan="1">365 (174)</td>
<td align="left" colspan="1" rowspan="1">162 (183)</td>
<td align="left" colspan="1" rowspan="1">114.81</td>
<td align="left" colspan="1" rowspan="1">1.15 (1.05, 1.27)</td>
<td align="left" colspan="1" rowspan="1">1.15 (1.04, 1.27)</td>
<td align="left" colspan="1" rowspan="1">1.56</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">1,291 (1.3)</td>
<td align="left" colspan="1" rowspan="1">143</td>
<td align="left" colspan="1" rowspan="1">365 (157)</td>
<td align="left" colspan="1" rowspan="1">168 (164)</td>
<td align="left" colspan="1" rowspan="1">141.33</td>
<td align="left" colspan="1" rowspan="1">1.42 (1.19, 1.68)</td>
<td align="left" colspan="1" rowspan="1">1.27 (1.02, 1.60)</td>
<td align="left" colspan="1" rowspan="1">1.87</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">I</td>
<td align="left" colspan="1" rowspan="1">6,351 (6.2)</td>
<td align="left" colspan="1" rowspan="1">612</td>
<td align="left" colspan="1" rowspan="1">365 (167)</td>
<td align="left" colspan="1" rowspan="1">129 (178)</td>
<td align="left" colspan="1" rowspan="1">124.47</td>
<td align="left" colspan="1" rowspan="1">1.25 (1.14, 1.37)</td>
<td align="left" colspan="1" rowspan="1">1.28 (1.16, 1.41)</td>
<td align="left" colspan="1" rowspan="1">1.88</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">J</td>
<td align="left" colspan="1" rowspan="1">1,308 (1.3)</td>
<td align="left" colspan="1" rowspan="1">167</td>
<td align="left" colspan="1" rowspan="1">365 (165)</td>
<td align="left" colspan="1" rowspan="1">149 (193)</td>
<td align="left" colspan="1" rowspan="1">163.91</td>
<td align="left" colspan="1" rowspan="1">1.64 (1.40, 1.93)</td>
<td align="left" colspan="1" rowspan="1">1.71 (1.41, 2.08)</td>
<td align="left" colspan="1" rowspan="1">2.81</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">K</td>
<td align="left" colspan="1" rowspan="1">1,771 (1.7)</td>
<td align="left" colspan="1" rowspan="1">210</td>
<td align="left" colspan="1" rowspan="1">365 (126)</td>
<td align="left" colspan="1" rowspan="1">146 (178)</td>
<td align="left" colspan="1" rowspan="1">145.68</td>
<td align="left" colspan="1" rowspan="1">1.46 (1.27, 1.69)</td>
<td align="left" colspan="1" rowspan="1">1.39 (1.18, 1.64)</td>
<td align="left" colspan="1" rowspan="1">2.13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">L</td>
<td align="left" colspan="1" rowspan="1">723 (0.7)</td>
<td align="left" colspan="1" rowspan="1">101</td>
<td align="left" colspan="1" rowspan="1">365 (119)</td>
<td align="left" colspan="1" rowspan="1">162 (166)</td>
<td align="left" colspan="1" rowspan="1">170.11</td>
<td align="left" colspan="1" rowspan="1">1.71 (1.40, 2.09)</td>
<td align="left" colspan="1" rowspan="1">1.96 (1.53, 2.49)</td>
<td align="left" colspan="1" rowspan="1">3.32</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p49">
<p>To facilitate the labeling of AD and BZD dose levels for each trajectory, we defined AD use as: negligible (standardized daily dose [SDD] &lt; 0.1 defined daily dose [DDD]), very low (0.1 to &lt; 0.5 DDD), low (0.5 to &lt; 1 DDD), moderate (1 to &lt; 1.5 DDD), high (1.5 to &lt; 2 DDD) and very high dose (≥ 2 DDD). Similarly, we defined BZD use as negligible (SDD &lt; 1 diazepam milligram equivalent [DME]), very-low (&lt; 5 DME), low (5 to &lt; 10 DME), moderate (10 to &lt; 15 DME), high (15 to &lt; 20 DME) and very-high dose (≥ 20 DME). We defined a “discontinuing” pattern as a dose reduction to the negligible level, “declining” or “increasing” patterns when the absolute change exceeded 0.1 DDD for ADs or 1 DME for BZDs, and “stable” when changes remained below these thresholds</p>
<p><sup>a</sup>Trajectory groups: A: low discontinuing AD (17.3% of the cohort); B: low declining AD (31.0%); C: moderate increasing AD (23.5%); D: high increasing AD (5.4%); E: low discontinuing AD/very-low declining BZD (4.0%); F: low discontinuing AD/low declining BZD (0.7%); G: low declining AD/very-low declining BZD (6.8%); H: low declining AD/low declining BZD (1.3%); I: moderate increasing AD/very-low declining BZD (6.2%); J: moderate increasing AD/low stable BZD (1.3%); K: very-high increasing AD/very-low stable BZD (1.7%); L: very-high increasing AD/low-dose increasing BZD (0.7%)</p>
</div></div></section><p id="Par42">Subgroup analyses yielded similar results for beneficiaries without frailty and those without dementia (Additional files: Table S7). However, among beneficiaries with frailty or dementia, no significant differences in FRI risk were observed across several trajectory groups, possibly due to limited sample sizes. Findings were consistent across all sensitivity analyses (Additional files: Table S7).</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par43">Using large national Medicare claims data, our findings provide important insights into the initiation of ADs with/without BZDs in older adults with depression. Notably, most of our cohort was prescribed low-dose ADs with a discontinuing or declining pattern—48.3% without BZD use and 12.8% with BZD use. Among patients receiving both ADs and BZDs (22.8%), very-low declining BZD was the most common utilization pattern (17.0%). For patients initiating ADs only, higher doses and longer durations were associated with an increased FRI risk (Groups B, C, and D vs. A), regardless of BZD use. Combining ADs and BZDs at a very-low dose or with a declining trend did not significantly alter the FRI risk compared to AD monotherapy (Group F vs. A), but the risk increased when BZDs were used at low-doses with stable or increasing trends (Group J vs. C; Group L vs. D).</p>
<p id="Par44">The majority of our study populations initiating both ADs and BZDs did not adhere to guideline recommendations against long-term BZD use [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>], a persistent concern given the known risk of adverse outcomes such as falls and fractures [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. For example, Bushnell et al. reported that 22% of patients initiating both ADs and BZDs continued receiving both medications for over six months [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Similarly, another study found that 14% of veterans with depression were on concurrent AD and BZD therapy for more than one year [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Our study adds to the existing literature by characterizing the longitudinal dosage patterns of ADs and BZDs and examining their associations with FRI risk. Notably, we observed that among older adults with depression, the most common BZD utilization pattern was very-low-dose and declining. This may reflect increasing clinical awareness of the risks associated with BZD use in this population and greater adherence to safety guidelines such as the Beers Criteria [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p>
<p id="Par45">Our study demonstrated that higher-dose and longer-term of AD use were associated with an increased FRI risk. While previous research has shown that ADs may elevate FRI risk, few studies have specifically examined the impact of AD dosage. Marcum et al. found that, compared to no use, moderate-dose AD use (SDD = 1–2 DDD) was associated with an increased FRI risk in community-dwelling older adults, whereas low-dose AD use (SDD &lt; 1 DDD) was not, suggesting a dose–response relationship between ADs and FRI risk [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. However, that study did not focus on AD use for depression, whereas our analysis was limited to patients with a depression diagnosis to reduce confounding by indication. Similarly, Bolton et al. and Vestergaard et al. reported that fracture risk significantly increased with higher doses of selective serotonin reuptake inhibitors and tricyclic antidepressants [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Our study extends these findings by comprehensively examining all classes of ADs and accounting for the concurrent use of multiple ADs to investigate the relationship between total AD dose and FRI risk.</p>
<p id="Par46">Existing evidence on the association between combined AD and BZD use and FRI risks remains inconsistent, with studies varying in their definitions of concurrent use and few examining BZD dosage patterns over time. For example, a self-controlled case series study found that concurrent use of BZDs with ADs was associated with a higher risk of fractures compared to AD monotherapy (incidence rate ratio = 1.88, 95%CI = 1.66–2.12) [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. However, the study defined concurrent BZD use as having any BZD prescription during AD treatment episodes, without accounting for BZD dose or duration [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. In contrast, Wagner et al. reported that the policy-driven reductions in BZD use among older adults did not decrease the incidence of hip fractures, suggesting no causal relationship between BZD use and hip fractures [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. That study defined BZD exposure as at least one BZD dispensing within one year before the policy implementation, again without considering dosage patterns. Our study adds to this body of evidence by incorporating longitudinal BZD dose trajectories. We found that combining ADs and BZDs at very-low doses or with declining trends did not significantly alter FRI risk compared to AD monotherapy. This may be due to improved management of depressive symptoms and severity, which are independently associated with increased FRI risk [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. In such cases, we hypothesized that the therapeutic benefit of improved depression symptoms and severity may offset the anticholinergic side effects of the medications [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Nevertheless, our findings also showed that FRI risk increased when BZDs were used at low-doses with stable or increasing trends, underscoring the need for cautious BZD use in older adults.</p>
<p id="Par47">Our study presents important clinical implications. First, we identified a potential dose–response relationship between AD use and FRI risk, highlighting the importance of initiating ADs at the lowest effective dose (&lt; 1 DDD) and regularly reassessing AD doses throughout treatment. Second, though we did not observe a clear dose–response relationship between BZD use and FRI risk within the 12-month timeframe, such relationship may emerge with longer-term or higher-dose of BZD use. This finding underscores the need for ongoing surveillance and monitoring in older adults receiving both ADs and BZDs. Third, we identified key covariates associated with AD ± BZD trajectory membership, which may help clinicians pinpoint patients requiring closer monitoring. Specifically, patients with dementia and those prescribed anticonvulsants, antidementia agents, antiparkinsonian agents, or antipsychotics were more likely to receive higher AD doses for a longer duration, placing them at greater FRI risk. Therefore, extra caution is warranted when prescribing ADs in these high-risk populations.</p>
<section id="Sec15"><h3 class="pmc_sec_title">Limitations</h3>
<p id="Par48">First, we excluded patients who died or experienced an FRI within 84 days of AD initiation to allow adequate classification of trajectory patterns. While this could introduce selection bias—particularly if event rates are high during the trajectory measurement period—the proportion excluded was low (2.4% among patients with depression), suggesting minimal impact on the overall findings. Second, despite adjusting for a broad set of covariates, unmeasured confounding may still be present. Factors such as depression or anxiety severity, lifestyle behaviors, functional status, and living environments—none of which are captured in claims data—could influence the observed associations. Ideally, a subgroup analysis stratified by depression severity (e.g., defined by hospitalization) would help to address the bias. However, a meaningful subgroup trajectory analysis is less likely feasible due to small sample sizes in our case, especially in the concurrent AD + BZD group. Therefore, the possibility of residual confounding by indication cannot be entirely excluded. That said, our E-value analysis suggests that an unmeasured confounder would need to be strongly associated with both the exposure and the outcome to fully explain away the observed effect estimates, supporting the robustness of our findings. Third, we adjusted for time-fixed but not time-varying confounders, as the included covariates (e.g., demographics, chronic comorbidities, chronic comedication use) are generally stable and unlikely to change substantially within the 84-day trajectory measurement window. This approach reduced analytical complexity in the trajectory analysis without compromising the validity of the results. Fourth, patients with dementia are likely to develop delirium, which is also an independent risk factor of FRI. While we adjusted for baseline dementia diagnoses, delirium is an acute condition that is often underdiagnosed and poorly captured in claims data, limiting its reliability as a covariate in claims-based analyses [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. Importantly, our study censored patients receiving care from skilled nursing facilities, who are more likely to have severe dementia and higher rates of delirium. This may help reduce confounding due to unmeasured severity of cognitive impairment. Fifth, this study focused on Medicare fee-for-service beneficiaries, which may limit the generalizability of our findings to other populations (e.g., young adults). In addition, we were unable to follow beneficiaries after they enrolled in Medicare Advantage, which covers slightly more than 50% of the Medicare population as of 2023 [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. This may limit the generalizability of our findings to the broader Medicare population [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. Sixth, reliance on administrative claims data may have introduced misclassification bias. For example, FRI events could be underreported if patients did not seek hospital care, and the actual medication use cannot be verified. Seventh, we were unable to account for treatment-emergent adverse effects such as hyponatremia—a known side effect of SSRIs that may increase FRI risk [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. Because hyponatremia can develop after antidepressant initiation and is not reliably captured in claims data, its role as an intermediate factor could not be evaluated in this study. Eighth, we identified nursing facility residents using Medicare-reimbursed skilled nursing facility claims. Because Medicare does not cover long-term custodial nursing home care, our approach may not fully capture long-term care residents who receive support through Medicaid or private pay. As such, some individuals with advanced frailty or cognitive impairment may have been misclassified as community-dwelling. Ninth, baseline hypertension was not adjusted, as evidence regarding its association with increased FRI risk remains inconsistent [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. Instead, hypotension [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>] and use of antihypertensive medications [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>] have been more consistently associated with elevated FRI risk. We have adjusted for these covariates in the baseline period. Tenth, while our study included dual-eligible beneficiaries, we acknowledge that Medicare claims may not fully capture certain services covered exclusively under Medicaid (e.g., long-term nursing home care, home- and community-based services), potentially leading to underestimation of some healthcare utilization. However, Medicare is the primary payer for most acute and outpatient medical care, and our exposures of interest (i.e., antidepressants and benzodiazepines) are covered under Medicare Part D and thus are expected to be well captured. Additionally, we excluded beneficiaries receiving hospice care or resided in skilled nursing facilities, as these settings may influence fall/fracture risk and confound medication exposure. Finally, dual eligibility was included as covariate and addressed through stabilized inverse probability of treatment weighting. While this remains a potential source of misclassification, the impact on our findings is likely limited given the nature of the exposures, the exclusion criteria applied, and the analytic adjustments. Despite these limitations, our sensitivity analyses yielded consistent results and E-values were large, indicating a robust association between AD ± BZD use trajectories and FRI risk.</p></section></section><section id="Sec16"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par49">Among fee-for-service Medicare beneficiaries with depression initiating ADs, we observed a dose–response relationship between AD use and FRI risk. Combining ADs and BZDs at a very-low dose or with a declining trend did not significantly alter the FRI risk compared to AD monotherapy, but the risk increased when BZDs were used at low-doses with stable or increasing trends. Our findings highlight the importance of initiating ADs at the lowest effective dose in older adults with depression and emphasize the need for careful evaluation and monitoring to prevent FRI.</p></section><section id="Sec17"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12366386/bin/12916_2025_4325_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12916_2025_4325_MOESM1_ESM.docx</a><sup> (308.4KB, docx) </sup><p>Additional file 1: Table S1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist. Table S2. Equivalency Conversion Table for Antidepressants and Benzodiazepines. Table S3. Nagin’s Diagnostic Criteria for Group-Based Multi-Trajectory Models of Antidepressant and Benzodiazepine Use among Medicare Beneficiaries (n=102,750). Table S4. International Classification of Diseases Clinical Modification Codes for Fall and Related Injuries. Table S5. International Classification of Diseases Clinical Modification Codes for Clinical Characteristics. Table S6. Detailed patient characteristics of eligible Medicare beneficiaries: Overall and by trajectory. Table S7. Trajectories of Antidepressant and Benzodiazepine Utilization Patterns and Risk of Falls and Related Injuries: Subgroup and Sensitivity analyses. Figure S1. Study Design Schematic Diagram. Figure S2. Cohort Selection Flowchart.</p>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>AD</dt>
<dd><p id="Par5">Antidepressant</p></dd>
<dt>ASMD</dt>
<dd><p id="Par6">Absolute standardized mean difference</p></dd>
<dt>BZD</dt>
<dd><p id="Par7">Benzodiazepine</p></dd>
<dt>CI</dt>
<dd><p id="Par8">Confidence interval</p></dd>
<dt>DDD</dt>
<dd><p id="Par9">Defined daily dose</p></dd>
<dt>DME</dt>
<dd><p id="Par10">Diazepam milligram equivalent</p></dd>
<dt>FRI</dt>
<dd><p id="Par11">Falls and related injuries</p></dd>
<dt>GBMTM</dt>
<dd><p id="Par12">Group-based multi-trajectory modeling</p></dd>
<dt>HR</dt>
<dd><p id="Par13">Hazard ratio</p></dd>
<dt>IPTW</dt>
<dd><p id="Par14">Inverse probability of treatment weighting</p></dd>
<dt>OR</dt>
<dd><p id="Par15">Odds ratio</p></dd>
<dt>PS</dt>
<dd><p id="Par16">Propensity score</p></dd>
<dt>SD</dt>
<dd><p id="Par17">Standard deviation</p></dd>
<dt>SDD</dt>
<dd><p id="Par18">Standardized daily dose</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>GH-MW and W-HL-C have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: GH-MW and W-HL-C. Acquisition, analysis, or interpretation of data: GH-MW, AG, RR, RS, TP, and W-HL-C. Drafting of the manuscript: GH-MW. Critical review of the manuscript for important intellectual content: GH-MW, AG, RR, RS, TP, and W-HL-C. Statistical analysis: GH-MW. Administrative, technical, or material support: GH-MW. Supervision: W-HL-C. All authors read and approved the final manuscript.</p>
<section id="FPar1"><h3 class="pmc_sec_title">Authors’ Twitter handles</h3>
<p id="Par50">Grace Hsin-Min Wang: X: @GraceWahaha.</p>
<p id="Par51">Amie J Goodin: Not applicable.</p>
<p id="Par52">Rachel C Reise: Not applicable.</p>
<p id="Par53">Ronald I Shorr: Not applicable.</p>
<p id="Par54">Taewoo Park: Not applicable.</p>
<p id="Par55">Wei-Hsuan Lo-Ciganic: BlueSky: @jennyciganic, X: @jennyciganic.</p></section></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets generated or analyzed during this study are not publicly available due to regulations set by the CMS regarding the use of Research Identifiable Files (RIFs). Access to the data requires researchers to submit a formal data request and obtain approval through the Research Data Assistance Center (ResDAC). For more information on the request process, please visit [<a href="https://resdac.org/cms-research-identifiable-request-process-timeline" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://resdac.org/cms-research-identifiable-request-process-timeline</a>].</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar2"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par56">Per Centers for Medicare &amp; Medicaid Services (CMS) policy, informed consent is not required for research involving limited datasets, provided the use complies with the CMS Data Use Agreement (DUA) and all applicable privacy and security requirements. The study used limited datasets including dates of diagnosis, prescriptions, and healthcare utilization. This research was conducted under an approved DUA (RSCH-2024–70191), and the University of Florida Institutional Review Board (IRB202301515) granted a waiver of informed consent consistent with Health Insurance Portability and Accountability Act (HIPAA) provisions for secondary research using de-identified or limited datasets.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par57">Not applicable.</p></section><section id="FPar4"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par58">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.
</cite> [<a href="https://doi.org/10.1186/s12991-021-00375-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8684627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34922595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zenebe%20Y,%20Akele%20B,%20W/Selassie%20M,%20Necho%20M.%20Prevalence%20and%20determinants%20of%20depression%20among%20old%20age:%20a%20systematic%20review%20and%20meta-analysis.%20Ann%20Gen%20Psychiatry.%202021;20(1):55." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatr. 2018;75(4):336–46.</cite> [<a href="https://doi.org/10.1001/jamapsychiatry.2017.4602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5875313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29450462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hasin%20DS,%20Sarvet%20AL,%20Meyers%20JL,%20Saha%20TD,%20Ruan%20WJ,%20Stohl%20M,%20et%20al.%20Epidemiology%20of%20adult%20DSM-5%20major%20depressive%20disorder%20and%20its%20specifiers%20in%20the%20United%20States.%20JAMA%20Psychiatr.%202018;75(4):336%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, Furukawa TA. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD001026. 10.1002/14651858. CD001026.pub2. Accessed 07 Aug 2025.</cite> [<a href="https://doi.org/10.1002/14651858.CD001026.pub2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31158298/" class="usa-link">PubMed</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Uher R, Mors O, Rietschel M, Rajewska-Rager A, Petrovic A, Zobel A, et al. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. J Clin Psychiatry. 2011;72(11):5274.</cite> [<a href="https://doi.org/10.4088/JCP.10m06419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22127194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Uher%20R,%20Mors%20O,%20Rietschel%20M,%20Rajewska-Rager%20A,%20Petrovic%20A,%20Zobel%20A,%20et%20al.%20Early%20and%20delayed%20onset%20of%20response%20to%20antidepressants%20in%20individual%20trajectories%20of%20change%20during%20treatment%20of%20major%20depression:%20a%20secondary%20analysis%20of%20data%20from%20the%20Genome-Based%20Therapeutic%20Drugs%20for%20Depression%20(GENDEP)%20study.%20J%20Clin%20Psychiatry.%202011;72(11):5274." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Bushnell GA, Stürmer T, Gaynes BN, Pate V, Miller M. Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001–2014. JAMA Psychiatr. 2017;74(7):747–55.</cite> [<a href="https://doi.org/10.1001/jamapsychiatry.2017.1273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5710248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28593281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bushnell%20GA,%20St%C3%BCrmer%20T,%20Gaynes%20BN,%20Pate%20V,%20Miller%20M.%20Simultaneous%20antidepressant%20and%20benzodiazepine%20new%20use%20and%20subsequent%20long-term%20benzodiazepine%20use%20in%20adults%20with%20depression,%20United%20States,%202001%E2%80%932014.%20JAMA%20Psychiatr.%202017;74(7):747%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Pfeiffer PN, Ganoczy D, Zivin K, Valenstein M. Benzodiazepines and adequacy of initial antidepressant treatment for depression. J Clin Psychopharmacol. 2011;31(3):360.
</cite> [<a href="https://doi.org/10.1097/JCP.0b013e318217b4c4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3101497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21508865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pfeiffer%20PN,%20Ganoczy%20D,%20Zivin%20K,%20Valenstein%20M.%20Benzodiazepines%20and%20adequacy%20of%20initial%20antidepressant%20treatment%20for%20depression.%20J%20Clin%20Psychopharmacol.%202011;31(3):360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Evans JG. Drugs and falls in later life. Lancet. 2003;361(9356):448.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(03)12502-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12583941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Evans%20JG.%20Drugs%20and%20falls%20in%20later%20life.%20Lancet.%202003;361(9356):448." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Laberge S, Crizzle AM. A literature review of psychotropic medications and alcohol as risk factors for falls in community dwelling older adults. Clin Drug Investig. 2019;39:117–39.
</cite> [<a href="https://doi.org/10.1007/s40261-018-0721-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30560350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Laberge%20S,%20Crizzle%20AM.%20A%20literature%20review%20of%20psychotropic%20medications%20and%20alcohol%20as%20risk%20factors%20for%20falls%20in%20community%20dwelling%20older%20adults.%20Clin%20Drug%20Investig.%202019;39:117%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Seppala LJ, Wermelink AM, de Vries M, Ploegmakers KJ, van de Glind EM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371 e11-. e17.</cite> [<a href="https://doi.org/10.1016/j.jamda.2017.12.098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29402652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seppala%20LJ,%20Wermelink%20AM,%20de%20Vries%20M,%20Ploegmakers%20KJ,%20van%20de%20Glind%20EM,%20Daams%20JG,%20et%20al.%20Fall-risk-increasing%20drugs:%20a%20systematic%20review%20and%20meta-analysis:%20II.%20Psychotropics.%20J%20Am%20Med%20Dir%20Assoc.%202018;19(4):371%20e11-.%20e17." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Panel AGSBCUE, Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.
</cite> [<a href="https://doi.org/10.1111/jgs.15767" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30693946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panel%20AGSBCUE,%20Fick%20DM,%20Semla%20TP,%20Steinman%20M,%20Beizer%20J,%20Brandt%20N,%20et%20al.%20American%20Geriatrics%20Society%202019%20updated%20AGS%20Beers%20Criteria%C2%AE%20for%20potentially%20inappropriate%20medication%20use%20in%20older%20adults.%20J%20Am%20Geriatr%20Soc.%202019;67(4):674%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Marcum ZA, Perera S, Thorpe JM, Switzer GE, Castle NG, Strotmeyer ES, et al. Antidepressant use and recurrent falls in community-dwelling older adults: findings from the Health ABC study. Ann Pharmacother. 2016;50(7):525–33.
</cite> [<a href="https://doi.org/10.1177/1060028016644466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4892949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27066988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marcum%20ZA,%20Perera%20S,%20Thorpe%20JM,%20Switzer%20GE,%20Castle%20NG,%20Strotmeyer%20ES,%20et%20al.%20Antidepressant%20use%20and%20recurrent%20falls%20in%20community-dwelling%20older%20adults:%20findings%20from%20the%20Health%20ABC%20study.%20Ann%20Pharmacother.%202016;50(7):525%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Sterke CS, Ziere G, van Beeck EF, Looman CW, van der Cammen TJ. Dose–response relationship between selective serotonin re-uptake inhibitors and injurious falls: a study in nursing home residents with dementia. Br J Clin Pharmacol. 2012;73(5):812–20.
</cite> [<a href="https://doi.org/10.1111/j.1365-2125.2011.04124.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3403209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22486601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sterke%20CS,%20Ziere%20G,%20van%20Beeck%20EF,%20Looman%20CW,%20van%20der%20Cammen%20TJ.%20Dose%E2%80%93response%20relationship%20between%20selective%20serotonin%20re-uptake%20inhibitors%20and%20injurious%20falls:%20a%20study%20in%20nursing%20home%20residents%20with%20dementia.%20Br%20J%20Clin%20Pharmacol.%202012;73(5):812%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(07)61602-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18064739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Von%20Elm%20E,%20Altman%20DG,%20Egger%20M,%20Pocock%20SJ,%20G%C3%B8tzsche%20PC,%20Vandenbroucke%20JP.%20The%20strengthening%20the%20reporting%20of%20observational%20studies%20in%20epidemiology%20(STROBE)%20statement:%20guidelines%20for%20reporting%20observational%20studies.%20Lancet.%202007;370(9596):1453%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, et al. Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017;9:267–77.
</cite> [<a href="https://doi.org/10.2147/CLEP.S105613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5433516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28533698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mues%20KE,%20Liede%20A,%20Liu%20J,%20Wetmore%20JB,%20Zaha%20R,%20Bradbury%20BD,%20et%20al.%20Use%20of%20the%20Medicare%20database%20in%20epidemiologic%20and%20health%20services%20research:%20a%20valuable%20source%20of%20real-world%20evidence%20on%20the%20older%20and%20disabled%20populations%20in%20the%20US.%20Clin%20Epidemiol.%202017;9:267%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, et al. Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017. 10.2147/CLEP.S105613.
</cite> [<a href="https://doi.org/10.2147/CLEP.S105613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5433516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28533698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mues%20KE,%20Liede%20A,%20Liu%20J,%20Wetmore%20JB,%20Zaha%20R,%20Bradbury%20BD,%20et%20al.%20Use%20of%20the%20Medicare%20database%20in%20epidemiologic%20and%20health%20services%20research:%20a%20valuable%20source%20of%20real-world%20evidence%20on%20the%20older%20and%20disabled%20populations%20in%20the%20US.%20Clin%20Epidemiol.%202017.%2010.2147/CLEP.S105613." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain R, et al. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharm. 2006;12(1):43–54.
</cite> [<a href="https://doi.org/10.18553/jmcp.2006.12.1.43" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10437648/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16420107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Robinson%20RL,%20Long%20SR,%20Chang%20S,%20Able%20S,%20Baser%20O,%20Obenchain%20R,%20et%20al.%20Higher%20costs%20and%20therapeutic%20factors%20associated%20with%20adherence%20to%20NCQA%20HEDIS%20antidepressant%20medication%20management%20measures:%20analysis%20of%20administrative%20claims.%20J%20Manag%20Care%20Pharm.%202006;12(1):43%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry. 1991;52:28–34.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1903134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kupfer%20DJ.%20Long-term%20treatment%20of%20depression.%20J%20Clin%20Psychiatry.%201991;52:28%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Med Res. 2018;27(7):2015–23.</cite> [<a href="https://doi.org/10.1177/0962280216673085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29846144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagin%20DS,%20Jones%20BL,%20Passos%20VL,%20Tremblay%20RE.%20Group-based%20multi-trajectory%20modeling.%20Stat%20Med%20Res.%202018;27(7):2015%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>L. Jones B, Nagin D. A Stata Plugin for Estimating Group-Based Trajectory Models [Internet]. Carnegie Mellon University; 2018. Cited 2025 Aug 3. Available from: <a href="https://kilthub.cmu.edu/articles/journalcontribution/A_Stata_Plugin_for_Estimating_Group-Based_Trajectory_Models/6470963/1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://kilthub.cmu.edu/articles/journalcontribution/A_Stata_Plugin_for_Estimating_Group-Based_Trajectory_Models/6470963/1</a></cite>
</li>
<li id="CR20">
<span class="label">20.</span><cite>Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10(1):3–12.
</cite> [<a href="https://doi.org/10.1111/j.1524-4733.2006.00139.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17261111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peterson%20AM,%20Nau%20DP,%20Cramer%20JA,%20Benner%20J,%20Gwadry-Sridhar%20F,%20Nichol%20M.%20A%20checklist%20for%20medication%20compliance%20and%20persistence%20studies%20using%20retrospective%20databases.%20Value%20Health.%202007;10(1):3%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Loucks J, Zuckerman AD, Berni A, Saulles A, Thomas G, Alonzo A. Proportion of days covered as a measure of medication adherence. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022;79(6):492–6.
</cite> [<a href="https://doi.org/10.1093/ajhp/zxab392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34637496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Loucks%20J,%20Zuckerman%20AD,%20Berni%20A,%20Saulles%20A,%20Thomas%20G,%20Alonzo%20A.%20Proportion%20of%20days%20covered%20as%20a%20measure%20of%20medication%20adherence.%20American%20journal%20of%20health-system%20pharmacy%E2%80%AF:%20AJHP%E2%80%AF:%20official%20journal%20of%20the%20American%20Society%20of%20Health-System%20Pharmacists.%202022;79(6):492%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Merlo J, Wessling A, Melander A. Comparison of dose standard units for drug utilisation studies. Eur J Clin Pharmacol. 1996;50:27–30.
</cite> [<a href="https://doi.org/10.1007/s002280050064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8739807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Merlo%20J,%20Wessling%20A,%20Melander%20A.%20Comparison%20of%20dose%20standard%20units%20for%20drug%20utilisation%20studies.%20Eur%20J%20Clin%20Pharmacol.%201996;50:27%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Abimbola Farinde, PharmD, PhD. Benzodiazepine Equivalency Chart: Benzodiazepine Equivalency. Medscape.com. Medscape; 2024. Cited 2025 Aug 3. Available from: <a href="https://emedicine.medscape.com/article/2172250-overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://emedicine.medscape.com/article/2172250-overview</a></cite>
</li>
<li id="CR24">
<span class="label">24.</span><cite>Bope ET, Kellerman RD, Conn HF. Conn’s current therapy 2016. Philadelphia, Pa: Elsevier; 2016. p. 969–1004.</cite> [<a href="https://scholar.google.com/scholar_lookup?Bope%20ET,%20Kellerman%20RD,%20Conn%20HF.%20Conn%E2%80%99s%20current%20therapy%202016.%20Philadelphia,%20Pa:%20Elsevier;%202016.%20p.%20969%E2%80%931004." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Mdcalc.com. 2023. Cited 2025 Aug 3. Available from: <a href="https://www.mdcalc.com/calc/10091/benzodiazepine-conversion-calculator" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdcalc.com/calc/10091/benzodiazepine-conversion-calculator</a></cite>
</li>
<li id="CR26">
<span class="label">26.</span><cite>Weichle T, Hynes DM, Durazo-Arvizu R, Tarlov E, Zhang Q. Impact of alternative approaches to assess outlying and influential observations on health care costs. Springerplus. 2013;2(1):1–11.
</cite> [<a href="https://doi.org/10.1186/2193-1801-2-614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3843184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24303338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weichle%20T,%20Hynes%20DM,%20Durazo-Arvizu%20R,%20Tarlov%20E,%20Zhang%20Q.%20Impact%20of%20alternative%20approaches%20to%20assess%20outlying%20and%20influential%20observations%20on%20health%20care%20costs.%20Springerplus.%202013;2(1):1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Lo-Ciganic WH, Hincapie-Castillo J, Wang T, Ge Y, Jones BL, Huang JL, et al. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models. Addiction. 2022;117(7):1982–97.
</cite> [<a href="https://doi.org/10.1111/add.15857" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11863753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35224799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lo-Ciganic%20WH,%20Hincapie-Castillo%20J,%20Wang%20T,%20Ge%20Y,%20Jones%20BL,%20Huang%20JL,%20et%20al.%20Dosing%20profiles%20of%20concurrent%20opioid%20and%20benzodiazepine%20use%20associated%20with%20overdose%20risk%20among%20US%20Medicare%20beneficiaries:%20group-based%20multi-trajectory%20models.%20Addiction.%202022;117(7):1982%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.
</cite> [<a href="https://doi.org/10.1146/annurev.clinpsy.121208.131413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20192788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagin%20DS,%20Odgers%20CL.%20Group-based%20trajectory%20modeling%20in%20clinical%20research.%20Annu%20Rev%20Clin%20Psychol.%202010;6:109%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>WHOCC. WHOCC - ATC/DDD Index. Whocc.no. 2019. Cited 2025 Aug 3. Available from: <a href="https://www.whocc.no/atc_ddd_index/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.whocc.no/atc_ddd_index/</a></cite>
</li>
<li id="CR30">
<span class="label">30.</span><cite>Rush J. UpToDate. Uptodate.com. 2019. Cited 2025 Aug 3. Available from: <a href="https://www.uptodate.com/contents/unipolar-major-depression-in-adults-choosing-initial-treatment" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.uptodate.com/contents/unipolar-major-depression-in-adults-choosing-initial-treatment</a></cite>
</li>
<li id="CR31">
<span class="label">31.</span><cite>Brandt J, Alkabanni W, Alessi-Severini S, Leong C. Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting. Clin Drug Investig. 2018;38:565–72.
</cite> [<a href="https://doi.org/10.1007/s40261-018-0648-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29619753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brandt%20J,%20Alkabanni%20W,%20Alessi-Severini%20S,%20Leong%20C.%20Translating%20benzodiazepine%20utilization%20data%20into%20meaningful%20population%20exposure:%20integration%20of%20two%20metrics%20for%20improved%20reporting.%20Clin%20Drug%20Investig.%202018;38:565%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Abimbola Farinde, PharmD, PhD. Benzodiazepine Equivalency Chart: Benzodiazepine Equivalency. Medscape.com. Medscape; 2024. Cited 2025 Aug 3. Available from: <a href="https://emedicine.medscape.com/article/2172250-overview#showall" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://emedicine.medscape.com/article/2172250-overview#showall</a></cite>
</li>
<li id="CR33">
<span class="label">33.</span><cite>Benzodiazepine Conversion Calculator. MDCalc. 2024 Cited 2025 Aug 3. Available from: <a href="https://www.mdcalc.com/benzodiazepine-conversion-calculator#evidence" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdcalc.com/benzodiazepine-conversion-calculator#evidence</a></cite>
</li>
<li id="CR34">
<span class="label">34.</span><cite>Borrelli EP, Bratberg J, Hallowell BD, Greaney ML, Kogut SJ. Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018. J Manag Care Spec Pharm. 2022;28(1):58–68.
</cite> [<a href="https://doi.org/10.18553/jmcp.2022.28.1.58" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10373022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34949119/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Borrelli%20EP,%20Bratberg%20J,%20Hallowell%20BD,%20Greaney%20ML,%20Kogut%20SJ.%20Application%20of%20a%20diazepam%20milligram%20equivalency%20algorithm%20to%20assess%20benzodiazepine%20dose%20intensity%20in%20Rhode%20Island%20in%202018.%20J%20Manag%20Care%20Spec%20Pharm.%202022;28(1):58%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105(5):488–95.
</cite> [<a href="https://doi.org/10.1093/oxfordjournals.aje.a112408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/871121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Copeland%20KT,%20Checkoway%20H,%20McMichael%20AJ,%20Holbrook%20RH.%20Bias%20due%20to%20misclassification%20in%20the%20estimation%20of%20relative%20risk.%20Am%20J%20Epidemiol.%201977;105(5):488%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Min L, Tinetti M, Langa KM, Ha J, Alexander N, Hoffman GJ. Measurement of fall injury with health care system data and assessment of inclusiveness and validity of measurement models. JAMA Netw Open. 2019;2(8):e199679-e.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2019.9679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6707014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31433480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Min%20L,%20Tinetti%20M,%20Langa%20KM,%20Ha%20J,%20Alexander%20N,%20Hoffman%20GJ.%20Measurement%20of%20fall%20injury%20with%20health%20care%20system%20data%20and%20assessment%20of%20inclusiveness%20and%20validity%20of%20measurement%20models.%20JAMA%20Netw%20Open.%202019;2(8):e199679-e." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>De Jong MR, Van der Elst M, Hartholt KA. Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf. 2013;4(4):147–54.
</cite> [<a href="https://doi.org/10.1177/2042098613486829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4125318/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25114778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Jong%20MR,%20Van%20der%20Elst%20M,%20Hartholt%20KA.%20Drug-related%20falls%20in%20older%20patients:%20implicated%20drugs,%20consequences,%20and%20possible%20prevention%20strategies.%20Ther%20Adv%20Drug%20Saf.%202013;4(4):147%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Austin SR, Wong Y-N, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med Care. 2015;53(9):e65.
</cite> [<a href="https://doi.org/10.1097/MLR.0b013e318297429c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3818341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23703645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Austin%20SR,%20Wong%20Y-N,%20Uzzo%20RG,%20Beck%20JR,%20Egleston%20BL.%20Why%20summary%20comorbidity%20measures%20such%20as%20the%20Charlson%20comorbidity%20index%20and%20Elixhauser%20score%20work.%20Med%20Care.%202015;53(9):e65." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15(1):1–14.
</cite> [<a href="https://doi.org/10.1186/s12877-015-0029-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4377853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25879993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salahudeen%20MS,%20Duffull%20SB,%20Nishtala%20PS.%20Anticholinergic%20burden%20quantified%20by%20anticholinergic%20risk%20scales%20and%20adverse%20outcomes%20in%20older%20people:%20a%20systematic%20review.%20BMC%20Geriatr.%202015;15(1):1%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10.
</cite> [<a href="https://doi.org/10.1186/s12877-017-0621-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5635569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29017448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Masnoon%20N,%20Shakib%20S,%20Kalisch-Ellett%20L,%20Caughey%20GE.%20What%20is%20polypharmacy?%20A%20systematic%20review%20of%20definitions.%20BMC%20Geriatr.%202017;17:1%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Haviland A, Nagin DS, Rosenbaum PR, Tremblay RE. Combining group-based trajectory modeling and propensity score matching for causal inferences in nonexperimental longitudinal data. Dev Psychol. 2008;44(2):422.
</cite> [<a href="https://doi.org/10.1037/0012-1649.44.2.422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18331133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haviland%20A,%20Nagin%20DS,%20Rosenbaum%20PR,%20Tremblay%20RE.%20Combining%20group-based%20trajectory%20modeling%20and%20propensity%20score%20matching%20for%20causal%20inferences%20in%20nonexperimental%20longitudinal%20data.%20Dev%20Psychol.%202008;44(2):422." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Winn AN, Fergestrom NM, Neuner JM. Using group based trajectory models and propensity score weighting to detect heterogeneous treatment effects: the case study of generic hormonal therapy for women with breast cancer. Med Care. 2019;57(1):85.
</cite> [<a href="https://doi.org/10.1097/MLR.0000000000001019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6291347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30489546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Winn%20AN,%20Fergestrom%20NM,%20Neuner%20JM.%20Using%20group%20based%20trajectory%20models%20and%20propensity%20score%20weighting%20to%20detect%20heterogeneous%20treatment%20effects:%20the%20case%20study%20of%20generic%20hormonal%20therapy%20for%20women%20with%20breast%20cancer.%20Med%20Care.%202019;57(1):85." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32(19):3388–414.
</cite> [<a href="https://doi.org/10.1002/sim.5753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3710547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23508673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McCaffrey%20DF,%20Griffin%20BA,%20Almirall%20D,%20Slaughter%20ME,%20Ramchand%20R,%20Burgette%20LF.%20A%20tutorial%20on%20propensity%20score%20estimation%20for%20multiple%20treatments%20using%20generalized%20boosted%20models.%20Stat%20Med.%202013;32(19):3388%E2%80%93414." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Stürmer T, Webster-Clark M, Lund JL, Wyss R, Ellis AR, Lunt M, et al. Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: a simulation study. Am J Epidemiol. 2021;190(8):1659–70.
</cite> [<a href="https://doi.org/10.1093/aje/kwab041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8327194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33615349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?St%C3%BCrmer%20T,%20Webster-Clark%20M,%20Lund%20JL,%20Wyss%20R,%20Ellis%20AR,%20Lunt%20M,%20et%20al.%20Propensity%20score%20weighting%20and%20trimming%20strategies%20for%20reducing%20variance%20and%20bias%20of%20treatment%20effect%20estimates:%20a%20simulation%20study.%20Am%20J%20Epidemiol.%202021;190(8):1659%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Li L, Greene T. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9(2):215–34.
</cite> [<a href="https://doi.org/10.1515/ijb-2012-0030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23902694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20L,%20Greene%20T.%20A%20weighting%20analogue%20to%20pair%20matching%20in%20propensity%20score%20analysis.%20Int%20J%20Biostat.%202013;9(2):215%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Petersen ML, Porter KE, Gruber S, Wang Y, Van Der Laan MJ. Diagnosing and responding to violations in the positivity assumption. Stat Med Res. 2012;21(1):31–54.</cite> [<a href="https://doi.org/10.1177/0962280210386207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4107929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21030422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Petersen%20ML,%20Porter%20KE,%20Gruber%20S,%20Wang%20Y,%20Van%20Der%20Laan%20MJ.%20Diagnosing%20and%20responding%20to%20violations%20in%20the%20positivity%20assumption.%20Stat%20Med%20Res.%202012;21(1):31%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424.</cite> [<a href="https://doi.org/10.1080/00273171.2011.568786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3144483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21818162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Austin%20PC.%20An%20introduction%20to%20propensity%20score%20methods%20for%20reducing%20the%20effects%20of%20confounding%20in%20observational%20studies.%20Multivar%20Behav%20Res.%202011;46(3):399%E2%80%93424." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution—a simulation study. Am J Epidemiol. 2010;172(7):843–54.
</cite> [<a href="https://doi.org/10.1093/aje/kwq198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3025652/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20716704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?St%C3%BCrmer%20T,%20Rothman%20KJ,%20Avorn%20J,%20Glynn%20RJ.%20Treatment%20effects%20in%20the%20presence%20of%20unmeasured%20confounding:%20dealing%20with%20observations%20in%20the%20tails%20of%20the%20propensity%20score%20distribution%E2%80%94a%20simulation%20study.%20Am%20J%20Epidemiol.%202010;172(7):843%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Olier I, Zhan Y, Liang X, Volovici V. Causal inference and observational data. BMC Med Res Methodol. 2023;23(1):227.
</cite> [<a href="https://doi.org/10.1186/s12874-023-02058-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10566026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37821812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Olier%20I,%20Zhan%20Y,%20Liang%20X,%20Volovici%20V.%20Causal%20inference%20and%20observational%20data.%20BMC%20Med%20Res%20Methodol.%202023;23(1):227." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Normand S-LT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–98.</cite> [<a href="https://doi.org/10.1016/s0895-4356(00)00321-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11297888/" class="usa-link">PubMed</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Kang JDY, Schafer JL. Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data. Stat Sci: Rev J Inst Math Stat. 2007;22(4):523–39. 10.1214/07-STS227.</cite> [<a href="https://doi.org/10.1214/07-STS227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2397555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18516239/" class="usa-link">PubMed</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239–41.</cite> [<a href="https://scholar.google.com/scholar_lookup?Schoenfeld%20D.%20Partial%20residuals%20for%20the%20proportional%20hazards%20regression%20model.%20Biometrika.%201982;69(1):239%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the US Medicare data. The Journals of Gerontology: Series A. 2020;75(6):1120–5.</cite> [<a href="https://doi.org/10.1093/gerona/glz224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7243587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31566201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20DH,%20Patorno%20E,%20Pawar%20A,%20Lee%20H,%20Schneeweiss%20S,%20Glynn%20RJ.%20Measuring%20frailty%20in%20administrative%20claims%20data:%20comparative%20performance%20of%20four%20claims-based%20frailty%20measures%20in%20the%20US%20Medicare%20data.%20The%20Journals%20of%20Gerontology:%20Series%20A.%202020;75(6):1120%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring frailty in Medicare data: development and validation of a claims-based frailty index. The Journals of Gerontology: Series A. 2018;73(7):980–7.</cite> [<a href="https://doi.org/10.1093/gerona/glx229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6001883/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29244057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20DH,%20Schneeweiss%20S,%20Glynn%20RJ,%20Lipsitz%20LA,%20Rockwood%20K,%20Avorn%20J.%20Measuring%20frailty%20in%20Medicare%20data:%20development%20and%20validation%20of%20a%20claims-based%20frailty%20index.%20The%20Journals%20of%20Gerontology:%20Series%20A.%202018;73(7):980%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. The Journals of Gerontology: Series A. 2019;74(8):1271–6.</cite> [<a href="https://doi.org/10.1093/gerona/gly197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6625579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30165612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20DH,%20Glynn%20RJ,%20Avorn%20J,%20Lipsitz%20LA,%20Rockwood%20K,%20Pawar%20A,%20et%20al.%20Validation%20of%20a%20claims-based%20frailty%20index%20against%20physical%20performance%20and%20adverse%20health%20outcomes%20in%20the%20health%20and%20retirement%20study.%20The%20Journals%20of%20Gerontology:%20Series%20A.%202019;74(8):1271%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Kim DH, Pawar A, Gagne JJ, Bessette LG, Lee H, Glynn RJ, et al. Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study. Ann Intern Med. 2021;174(9):1214–23.
</cite> [<a href="https://doi.org/10.7326/M20-7141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8453126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34280330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20DH,%20Pawar%20A,%20Gagne%20JJ,%20Bessette%20LG,%20Lee%20H,%20Glynn%20RJ,%20et%20al.%20Frailty%20and%20clinical%20outcomes%20of%20direct%20oral%20anticoagulants%20versus%20warfarin%20in%20older%20adults%20with%20atrial%20fibrillation:%20a%20cohort%20study.%20Ann%20Intern%20Med.%202021;174(9):1214%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Taylor DH Jr, Østbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. Journal of Alzheimer’s disease : JAD. 2009;17(4):807–15.
</cite> [<a href="https://doi.org/10.3233/JAD-2009-1099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3697480/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19542620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taylor%20DH%20Jr,%20%C3%98stbye%20T,%20Langa%20KM,%20Weir%20D,%20Plassman%20BL.%20The%20accuracy%20of%20Medicare%20claims%20as%20an%20epidemiological%20tool:%20the%20case%20of%20dementia%20revisited.%20Journal%20of%20Alzheimer%E2%80%99s%20disease%E2%80%AF:%20JAD.%202009;17(4):807%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Moura LM, Festa N, Price M, Volya M, Benson NM, Zafar S, et al. Identifying Medicare beneficiaries with dementia. J Am Geriatr Soc. 2021;69(8):2240–51.
</cite> [<a href="https://doi.org/10.1111/jgs.17183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8373730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33901296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moura%20LM,%20Festa%20N,%20Price%20M,%20Volya%20M,%20Benson%20NM,%20Zafar%20S,%20et%20al.%20Identifying%20Medicare%20beneficiaries%20with%20dementia.%20J%20Am%20Geriatr%20Soc.%202021;69(8):2240%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268–74.
</cite> [<a href="https://doi.org/10.7326/M16-2607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28693043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?VanderWeele%20TJ,%20Ding%20P.%20Sensitivity%20analysis%20in%20observational%20research:%20introducing%20the%20E-value.%20Ann%20Intern%20Med.%202017;167(4):268%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Fulone I, Silva MT, Lopes LC. Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study. BMJ Open. 2018;8(4):e018956.
</cite> [<a href="https://doi.org/10.1136/bmjopen-2017-018956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5892742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29627806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fulone%20I,%20Silva%20MT,%20Lopes%20LC.%20Long-term%20benzodiazepine%20use%20in%20patients%20taking%20antidepressants%20in%20a%20public%20health%20setting%20in%20Brazil:%20a%20cross-sectional%20study.%20BMJ%20Open.%202018;8(4):e018956." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350: h2698.
</cite> [<a href="https://doi.org/10.1136/bmj.h2698" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4462713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26063215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Park%20TW,%20Saitz%20R,%20Ganoczy%20D,%20Ilgen%20MA,%20Bohnert%20AS.%20Benzodiazepine%20prescribing%20patterns%20and%20deaths%20from%20drug%20overdose%20among%20US%20veterans%20receiving%20opioid%20analgesics:%20case-cohort%20study.%20BMJ.%202015;350:%20h2698." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol. 2008;28(4):384–91.
</cite> [<a href="https://doi.org/10.1097/JCP.0b013e31817d5943" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18626264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bolton%20JM,%20Metge%20C,%20Lix%20L,%20Prior%20H,%20Sareen%20J,%20Leslie%20WD.%20Fracture%20risk%20from%20psychotropic%20medications:%20a%20population-based%20analysis.%20J%20Clin%20Psychopharmacol.%202008;28(4):384%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Vestergaard P, Prieto-Alhambra D, Javaid MK, Cooper C. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos Int. 2013;24:671–80.
</cite> [<a href="https://doi.org/10.1007/s00198-012-2043-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3658008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22669469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vestergaard%20P,%20Prieto-Alhambra%20D,%20Javaid%20MK,%20Cooper%20C.%20Fractures%20in%20users%20of%20antidepressants%20and%20anxiolytics%20and%20sedatives:%20effects%20of%20age%20and%20dose.%20Osteoporos%20Int.%202013;24:671%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Yang BR, Lee E, Hwang BS, Lee SH, Kang Y-J, Jung S-Y. Risk of fracture in antidepressant users with concurrent use of benzodiazepines: a self-controlled case-series analysis. Bone. 2021;153: 116109.
</cite> [<a href="https://doi.org/10.1016/j.bone.2021.116109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34252602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20BR,%20Lee%20E,%20Hwang%20BS,%20Lee%20SH,%20Kang%20Y-J,%20Jung%20S-Y.%20Risk%20of%20fracture%20in%20antidepressant%20users%20with%20concurrent%20use%20of%20benzodiazepines:%20a%20self-controlled%20case-series%20analysis.%20Bone.%202021;153:%20116109." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007;146(2):96–103.
</cite> [<a href="https://doi.org/10.7326/0003-4819-146-2-200701160-00004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17227933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wagner%20AK,%20Ross-Degnan%20D,%20Gurwitz%20JH,%20Zhang%20F,%20Gilden%20DB,%20Cosler%20L,%20et%20al.%20Effect%20of%20New%20York%20State%20regulatory%20action%20on%20benzodiazepine%20prescribing%20and%20hip%20fracture%20rates.%20Ann%20Intern%20Med.%202007;146(2):96%E2%80%93103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>de Cates A, De Giorgi R. Antidepressants plus benzodiazepines in major depressive disorder: a clinical dilemma with no recent answers from research. BJPsych advances. 2020;26(6):321–6.
</cite> [<a href="https://doi.org/10.1192/bja.2020.17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34589233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Cates%20A,%20De%20Giorgi%20R.%20Antidepressants%20plus%20benzodiazepines%20in%20major%20depressive%20disorder:%20a%20clinical%20dilemma%20with%20no%20recent%20answers%20from%20research.%20BJPsych%20advances.%202020;26(6):321%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Wang GH, Lai EC, Goodin AJ, Reise RC, Shorr RI, Lo-Ciganic WH. Injurious fall risk differences among older adults with first-line depression treatments. JAMA Netw Open. 2024;7(8):e2435535.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.35535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12068830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39186265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20GH,%20Lai%20EC,%20Goodin%20AJ,%20Reise%20RC,%20Shorr%20RI,%20Lo-Ciganic%20WH.%20Injurious%20fall%20risk%20differences%20among%20older%20adults%20with%20first-line%20depression%20treatments.%20JAMA%20Netw%20Open.%202024;7(8):e2435535." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Chuen VL, Chan AC, Ma J, Alibhai SM, Chau V. Assessing the accuracy of international classification of diseases (ICD) coding for delirium. J Appl Gerontol. 2022;41(5):1485–90.
</cite> [<a href="https://doi.org/10.1177/07334648211067526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9024024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35176883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chuen%20VL,%20Chan%20AC,%20Ma%20J,%20Alibhai%20SM,%20Chau%20V.%20Assessing%20the%20accuracy%20of%20international%20classification%20of%20diseases%20(ICD)%20coding%20for%20delirium.%20J%20Appl%20Gerontol.%202022;41(5):1485%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Freed M, Fuglesten Biniek J, Damico A, Neuman T. Medicare Advantage in 2024: Enrollment Update and Key Trends | KFF . KFF. 2024. Cited 2025 Aug 3. Available from: <a href="https://www.kff.org/medicare/issue-brief/medicare-advantage-in-2024-enrollment-update-and-key-trends/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.kff.org/medicare/issue-brief/medicare-advantage-in-2024-enrollment-update-and-key-trends/</a></cite>
</li>
<li id="CR70">
<span class="label">70.</span><cite>Clerveau G, Ochieng N. A Snapshot of Sources of Coverage Among Medicare Beneficiaries. KFF. 2023. Cited 2025 Aug 3. Available from: <a href="https://www.kff.org/medicare/issue-brief/a-snapshot-of-sources-of-coverage-among-medicare-beneficiaries/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.kff.org/medicare/issue-brief/a-snapshot-of-sources-of-coverage-among-medicare-beneficiaries/</a></cite>
</li>
<li id="CR71">
<span class="label">71.</span><cite>Leth-Møller KB, Hansen AH, Torstensson M, Andersen SE, Ødum L, Gislasson G, et al. Antidepressants and the risk of hyponatremia: a Danish register-based population study. BMJ Open. 2016;6(5):e011200.
</cite> [<a href="https://doi.org/10.1136/bmjopen-2016-011200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4874104/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27194321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leth-M%C3%B8ller%20KB,%20Hansen%20AH,%20Torstensson%20M,%20Andersen%20SE,%20%C3%98dum%20L,%20Gislasson%20G,%20et%20al.%20Antidepressants%20and%20the%20risk%20of%20hyponatremia:%20a%20Danish%20register-based%20population%20study.%20BMJ%20Open.%202016;6(5):e011200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Klein D, Nagel G, Kleiner A, Ulmer H, Rehberger B, Concin H, et al. Blood pressure and falls in community-dwelling people aged 60 years and older in the VHM&amp;PP cohort. BMC Geriatr. 2013;13:1–7.
</cite> [<a href="https://doi.org/10.1186/1471-2318-13-50" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3663706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23692779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klein%20D,%20Nagel%20G,%20Kleiner%20A,%20Ulmer%20H,%20Rehberger%20B,%20Concin%20H,%20et%20al.%20Blood%20pressure%20and%20falls%20in%20community-dwelling%20people%20aged%2060%20years%20and%20older%20in%20the%20VHM&amp;PP%20cohort.%20BMC%20Geriatr.%202013;13:1%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Finucane C, Kenny RA. Falls risk, orthostatic hypotension, and optimum blood pressure management: is it all in our heads? Am J Hypertens. 2016. 10.1093/ajh/hpw129.
</cite> [<a href="https://doi.org/10.1093/ajh/hpw129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27831488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Finucane%20C,%20Kenny%20RA.%20Falls%20risk,%20orthostatic%20hypotension,%20and%20optimum%20blood%20pressure%20management:%20is%20it%20all%20in%20our%20heads?%20Am%20J%20Hypertens.%202016.%2010.1093/ajh/hpw129." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Abu Bakar AA, Abdul Kadir A, Idris NS, Mohd Nawi SN. Older adults with hypertension: prevalence of falls and their associated factors. Int J Environ Res Public Health. 2021. 10.3390/ijerph18168257.
</cite> [<a href="https://doi.org/10.3390/ijerph18168257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8392439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34444005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abu%20Bakar%20AA,%20Abdul%20Kadir%20A,%20Idris%20NS,%20Mohd%20Nawi%20SN.%20Older%20adults%20with%20hypertension:%20prevalence%20of%20falls%20and%20their%20associated%20factors.%20Int%20J%20Environ%20Res%20Public%20Health.%202021.%2010.3390/ijerph18168257." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366386/bin/12916_2025_4325_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12916_2025_4325_MOESM1_ESM.docx</a><sup> (308.4KB, docx) </sup><p>Additional file 1: Table S1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist. Table S2. Equivalency Conversion Table for Antidepressants and Benzodiazepines. Table S3. Nagin’s Diagnostic Criteria for Group-Based Multi-Trajectory Models of Antidepressant and Benzodiazepine Use among Medicare Beneficiaries (n=102,750). Table S4. International Classification of Diseases Clinical Modification Codes for Fall and Related Injuries. Table S5. International Classification of Diseases Clinical Modification Codes for Clinical Characteristics. Table S6. Detailed patient characteristics of eligible Medicare beneficiaries: Overall and by trajectory. Table S7. Trajectories of Antidepressant and Benzodiazepine Utilization Patterns and Risk of Falls and Related Injuries: Subgroup and Sensitivity analyses. Figure S1. Study Design Schematic Diagram. Figure S2. Cohort Selection Flowchart.</p>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated or analyzed during this study are not publicly available due to regulations set by the CMS regarding the use of Research Identifiable Files (RIFs). Access to the data requires researchers to submit a formal data request and obtain approval through the Research Data Assistance Center (ResDAC). For more information on the request process, please visit [<a href="https://resdac.org/cms-research-identifiable-request-process-timeline" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://resdac.org/cms-research-identifiable-request-process-timeline</a>].</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Medicine are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12916-025-04325-2"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12916_2025_Article_4325.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (925.2 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366386/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366386/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366386%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366386/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366386/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366386/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830788/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366386/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830788/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366386/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366386/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="7fBa2R8AQcYHYr8i9JtrFpdN0ZVE2wyDWfznnXdAvnNW1DRApr36LWUztKDpq6iQ">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
